Next Article in Journal
Carbon Monoxide Poisoning and Developing Ischemic Heart Disease: A Nationwide Population-Based Nested Case-Control Study
Next Article in Special Issue
A Hybrid Neural Network–Particle Swarm Optimization Informed Spatial Interpolation Technique for Groundwater Quality Mapping in a Small Island Province of the Philippines
Previous Article in Journal
The Peculiar Estrogenicity of Diethyl Phthalate: Modulation of Estrogen Receptor α Activities in the Proliferation of Breast Cancer Cells
Previous Article in Special Issue
Rapid Determination of Per- and Polyfluoroalkyl Substances (PFAS) in Harbour Porpoise Liver Tissue by HybridSPE®–UPLC®–MS/MS
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Method Scope Extension for the Simultaneous Analysis of POPs, Current-Use and Banned Pesticides, Rodenticides, and Pharmaceuticals in Liver. Application to Food Safety and Biomonitoring

by
Cristian Rial-Berriel
1,2,†,
Andrea Acosta-Dacal
1,†,
Manuel Zumbado
1,2,3,
Luis Alberto Henríquez-Hernández
1,2,3,
Ángel Rodríguez-Hernández
1,
Ana Macías-Montes
1,
Luis D. Boada
1,3,
María del Mar Travieso-Aja
4,
Beatriz Martin Cruz
1 and
Octavio P. Luzardo
1,2,3,*
1
Toxicology Unit, Research Institute of Biomedical and Health Sciences (IUIBS), Universidad de Las Palmas de Gran Canaria, Paseo Blas Cabrera s/n, 35016 Las Palmas de Gran Canaria, Spain
2
Study Group on Wild Animal Conservation Medicine (GEMAS), 28040 Madrid, Spain
3
Spanish Biomedical Research Center in Physiopathology of Obesity and Nutrition (CIBERObn), 28029 Madrid, Spain
4
Grupo Hospitalario San Roque, C/Dolores de la Rocha, 35001 Las Palmas de Gran Canaria, Spain
*
Author to whom correspondence should be addressed.
Shared first authors.
Toxics 2021, 9(10), 238; https://doi.org/10.3390/toxics9100238
Submission received: 5 September 2021 / Revised: 22 September 2021 / Accepted: 23 September 2021 / Published: 27 September 2021

Abstract

:
The screening of hundreds of substances belonging to multiple chemical classes in liver is required in areas such as food safety or biomonitoring. We adapted a previous QuEChERS-based method in blood to the liver matrix and applied to these fields of study. The validation of the method allowed the inclusion of 351 contaminants, 80% with a LOQ < 2 ng/g. In the analysis of 42 consumer liver samples, we detected trace levels of 29 different contaminants. The most frequent and concentrated was 4,4’-DDE. POPs accounted for 66% of the compounds detected. In no case was the MRL reached for any of the contaminants detected. We also applied the method to 151 livers of wild birds to perform a biomonitoring pilot study in the Canary Islands. We detected 52 contaminants in 15 bird species. These were also mostly POPs, although high frequencies and concentrations of anticoagulant rodenticides (AR) and some other agricultural pesticides also stand out. POPs and AR contamination levels were significantly higher in terrestrial birds, raptors and particularly in nocturnal birds. Pesticide contamination levels were also higher in terrestrial birds, as well as in non-raptors and diurnal birds. The validated method is simple, robust, and sensitive and performs well in a variety of practical scenarios, where it can be carried out relatively quickly and inexpensively.

Graphical Abstract

1. Introduction

Animal liver is a common matrix for the search of chemical residues for several reasons. On the one hand, the use of veterinary drugs, which is widely accepted in veterinary practice to treat bacterial infections, parasitism (internal or external), inflammation, and other animal diseases or their symptoms in livestock practice [1,2], may condition the appearance of residues of these chemicals in foods of animal origin, especially in the liver [3,4,5]. This is particularly relevant, since the presence of antimicrobial compounds can induce the spread of drug-resistant pathogenic bacterial strains or produce allergic reactions in humans [3,6]. In addition, pesticide products used in agriculture can leave residues in the raw materials used in the preparation of animal food, and these residues can in turn generate the appearance of residues in food products of animal origin [5], that can pose a serious risk to the health of consumers [6]. Therefore, to protect consumers from these undesirable effects, as a food safety measure, maximum residue limits (MRLs) have been established for many veterinary medicinal products and pesticides on a range of commodities of animal origin, including meat and meat products, liver, fish, honey, milk, and eggs [5,7]. According to the European regulations, the liver must be investigated for the presence of several hundred compounds, including pesticides commonly used in agriculture, pesticides already banned but of great environmental persistence, and also residues of veterinary drugs [7]. Although there are differences between countries, if we take as a common reference what is established in the Codex Alimentarius, there are at least maximum residue limits (MRLs) established for some 218 pesticides and for another 75 veterinary drugs (also including combinations of drugs and animal feed) [4,5].
On the other hand, wildlife lives in an environment that is increasingly contaminated with chemical substances (pesticides, industrial pollutants, wastewater, urban solid waste, etc.) and therefore can serve as first line indicators of the levels of pollutants and their possible health impacts [8,9,10]. Wildlife biomonitoring can provide important information about the bioavailability of contaminants in the environment humans share with these species [11,12,13], which supports the design of appropriate remediation strategies [14]. These data can result in substantial savings of limited remediation resources while maximizing the preservation of important natural areas and supporting effective site remediation [14]. The action of monitoring wildlife exposure to chemical contaminants is usually known as biomonitoring [10,15,16].
Like pesticides and pharmaceuticals, the annual use of anticoagulant rodenticides (ARs) for rodent control is measured in thousands of tons. This extensive use often leads to unintentional exposure of non-target animals, especially birds of prey, to these poisons, so there is a need for these substances to be included in biomonitoring studies. With regard to food safety, it should be noted that ARs are not authorized for use on edible crops within the EU, so the Codex Alimentarius Commission has not set MRLs for any of them, and residues of ARs are not expected to be present in any plant or animal products [17], and therefore they are not usually routinely investigated in food.
Whether it is for residue research in the context of food safety, or in the context of biomonitoring, the liver is an extremely interesting matrix, as it is one of the organs of that concentrates more quantity of chemicals [18]. The range of substances that it is interesting to investigate in one or another circumstance is quite similar, since the substances that are of concern from the point of view of food safety generally also concern from the point of view of the environmental pollution and their effects on wildlife [11,19,20,21]. The availability of multi-residue methods that are capable of accurately and simultaneously identifying and quantifying the concentration of any of these substances subjected to MRLs that may be present in the liver tissue is extremely interesting [5]. Therefore, it is necessary to develop multi-residue methods belonging to multiple chemical classes. In the case of biomonitoring, moreover, the challenge of detecting such a variety of potentially harmful substances in a complex matrix such as the liver is compounded by the fact that the amount of sample available is usually small [16].
Although there are numerous published multi-residue/multi-class methods for the determination of chemicals in animal liver, most focus either on the analysis of pesticides [22,23] or on the analysis of certain groups of veterinary drugs [24,25,26]. However, very few of the published methods address the simultaneous analysis of compounds from both classes [27], and are generally limited to a discrete number of compounds. Therefore, to cover the whole spectrum of compounds of interest in any of the fields (food safety and biomonitoring), it is usually necessary to apply several methods in a complementary manner, which consumes time, economic resources, and sample quantity, which may be limited in the case of wildlife.
The first part of this research consists of a validation of a method scope extension. The original method was developed for whole blood [16,28], and now it has been validated for liver matrix. But more interesting, probably, is the second part of our paper, in which we present and discuss the results of the application of this methodology to the two fields described. On the one hand we analyzed the residues of substances subjected to MRLs in 46 samples of liver intended for human consumption sampled, acquired in markets, supermarkets, and slaughterhouses. On the other hand, we applied the method to the biomonitoring of 151 wildlife specimens from the Canary Islands received in our service from mid-2020 to April 2021.

2. Materials and Methods

2.1. Certified Standards and Reagents

Methanol (MeOH, 99.9% purity), acetonitrile (ACN, 99.9% purity), and formic acid (FA, 98.0% purity), all LC-MS grade, were purchased from Honeywell (Charlotte, NC, USA). LC-Grade water (18.2 MΩ/cm) was purified by a MilliQ A10 Gradient system (Millipore, Molsheim, France). Ammonium acetate Optima LC-MS grade was purchased from Fisher (Fisher Scientific UK, Loughborough, UK). QuEChERS Extract Pouch, AOAC Method (6 g de magnesium sulphate and 1.5 g sodium acetate), were purchased in commercial premixes from Agilent Technologies (Palo Alto, CA, USA).
All certified standards (liquid or solid) of all the individual pollutants and deuterated compounds (P-ISs, procedural internal standards) were obtained from A2S—Analytical Standard Solutions (Staint Jean D’Illac, France), Sigma-Aldrich (Augsburg, Germany), CPA Chem (Stara Zagora, Bulgaria), European Pharmacopoeia Reference Standards (Strasbourg, France), Accustandard (New Haven, CT, USA), and Dr. Ehrestorfer (Augsburg, Germany). All standards were from the highest purity available (93.1% to 99.8%). Individual 1 mg/mL stock solutions of each pollutant were prepared either dissolving or diluting certified standards in ACN, MeOH, water, or acetone (according to the solubility of substances), and stored no more than a year at −32 °C. The standard solutions were sorted, grouping by pesticide, pharmaceuticals, COPs, or procedural internal standards (pIS) to get four intermediate solutions at 1 μg/mL/each. Matrix-matched calibration and quality control points were fortified independently, to get 11 points between 0.4 to 40 ng/mL, with 4 quality controls at 1, 4, 10, and 20 ng/mL.

2.2. Liver for Method Validation

For the development, optimization, and validation of the analytical technique, we employed liver samples obtained from chickens of an organic farm. All the chickens were born in this facility, were healthy and had never been exposed to chemicals (no farms or agricultural facilities in the nearby, and no pharmacological treatments, according to the standards of the production mode), to avoid drug interference. The livers were obtained directly from the slaughterhouse, when these animals were slaughtered for consumption, and placed in 50 mL propylene tubes. Upon arrival at the laboratory, these samples were immediately stored at −24 °C until use.

2.3. Sample Preparation and Extraction

The QuEChERS method [29] is a matrix dispersion extraction method, which was initially developed for the analysis of pesticides in fruits and vegetables, but has proven to be versatile, allowing the analysis of many other compounds in complex matrices such as blood, milk, meat, eggs, and even soil [30,31]. We applied it to liver samples, for which it is first necessary to homogenize the liver before applying the QuEChERS extraction. For this purpose, one gram of liver sample was weighed into a tube suitable for homogenization with a Precellys Evolution homogenizer (Bertin Technologies, Rockville, Washington D.C., USA), operated at 6500 rpm, 2 × 30 s. After that, when needed, the fortification was performed, either for validation experiments, for calibration curves, or for the preparation of the quality controls (QC). Then, the homogenate was diluted with 4 mL ultrapure water, and one milliliter of the diluted homogenate was placed in a 5 mL Eppendorf tube to be processed. Ten μL of pIS mix (acenaphthene-d10, atrazine-d5, carbendazim-d3, chlorpyrifos-d10, chrysene-d12, cyromazine-d4, diazinon-d10, linuron-d3, PCB 200, phenanthrene-d10, and pirimicarb-d6) was added to all the tubes (either fortified or not) to reach a final concentration of 10 ng/mL. Next, anhydrous magnesium sulfate (480 mg) and sodium acetate (120 mg) were added to each sample tube, followed by 30 s of vortexing and 1 min of vertical manual shaking. Finally, the Eppendorf tubes were centrifuged for 5 min, at 4500 rpm and 2 °C. The supernatant was then filtered through a 0.2 μm Chromafil PET-20/15 syringe filter (polyester, certified for HPLC, Macherey-Nagel, Düren, Germany) into an amber vial directly, for sequential LC and GC-MS/MS analysis.

2.4. Instrumental Analysis

We found that two complementary analyses are required to detect and quantify the 351 compounds that finally could be included in this method. Thus, an analysis by gas chromatography coupled to triple quadrupole mass spectrometry (GC-MS/MS) is needed for the analysis of the most volatile compounds (mainly persistent organic pollutants and some less polar pesticides) and an analysis by liquid chromatography coupled to triple quadrupole mass spectrometry (LC-MS/MS) for the pharmaceuticals, the rodenticides, and the most polar pesticides.

2.4.1. GC-MS/MS

Gas chromatography was employed for the separation of 126 compounds using an Agilent 7890B gas chromatograph (Agilent Technologies, Palo Alto, CA, USA). Two Agilent J&W HP-5MS (5% cross-linked phenyl-methyl-polysiloxane, Agilent Technologies) ultra-inert fused silica capillary columns, with a total length of 30 m (15 + 15), a film thickness of 0.25 μm and 0.25 mm in diameter, were employed for the separations. The columns were joined by means of a purged joint to allow the application of the back-flushing technique that reduces the background noise and extends the column lifetime. An ultra-inert glass wool inlet liner at 250 °C was used at the injection port, and the injection (1.5 µL) was performed in splitless pulsed mode. The gases used were supplied by Linde (Dublin, Ireland), the carrier gas being helium 5.0 (99.999% purity) at a constant flow 1.5 mL/min, and the collision gas being nitrogen 6.0 (99.9999% purity). The initial oven temperature of 80 °C was maintained for 1.8 min, then increased at a rate of 40 °C/min to 170 °C, then increased at a rate of 10 °C/min to 310 °C, and finally maintained for 3 min at 310 °C. The post-run backflush to clean the column was set at 315 °C for 5 min at −5.8 mL/min for the first column, and the final run time at 21.05 min. For the identification and quantification of the compounds, an Agilent 7010 mass spectrometer (Agilent Technologies, Palo Alto, CA, USA) was used. This equipment was operated in the multiple reaction monitoring mode (MRM), with 24-time segments, cycle time between 300 and 600 ms and a dwell time between 15 and 40 ms. The electron impact (EI) and transfer line ionization source temperatures were set at 280 °C, with a solvent delay of 3.7 min.

2.4.2. LC-MS/MS

Liquid chromatography was employed to separate 225 substances using an Agilent 1290 Infinity II UHPLC (Agilent Technologies, Palo Alto, CA, USA). The column was an InfinityLab Poroshell 120 (2.1 mm × 100 mm, 2.7 µm), coupled to an inline filter and an UHPLC guard column with the same characteristics as the analytical column, to protect the column. The gradient of mobile phase A was: 95%—0.5 min; 80%—1 min; 60%—2.5 min; 15%—8 min; 0%—10 to 14 min; 95%—14.01 min. Mobile phase A contained 0.1% FA and 2 mM ammonium acetate in ultrapure water; mobile phase B consisted of 2 mM ammonium acetate in MeOH. 8 μL were injected at a flow rate set at 0.4 mL/min and an oven column temperature of 50 °C. For identification and quantification, an Agilent 6460 mass spectrometer (Agilent Technologies, Palo Alto, CA, USA) was employed. It was operated in the dynamic multiple reaction monitoring mode (dMRM), in both positive and negative polarities, with a cycle time 800 ms, a dwell time of 8 to 60 ms, and a total run time of 18 min. The Agilent Jet Stream Electrospray Ionization Source (AJS-ESI) was operated under the following conditions: gas temperature 190 °C; nebulizer gas flow and pressure were 11 L/min and 26 psi, respectively; the temperature of the sheath gas and the flow were 330 °C and 12 L/min, respectively; and the positive and negative capillary voltages were 3900 V and 2600 V. The drying and desolvation gas was nitrogen provided by the Zefiro 40 nitrogen generator (F-DGSi, Evry, France). Nitrogen 6.0 (99.9999% purity, Linde, Dublin, Ireland) was used as the collision gas.

2.5. Validation Procedures

Although this is an extension of the analytical scope of a previous method [16]—in this case a change of matrix—it is necessary to undertake a validation process to verify the capacity of the assay to obtain satisfactory results for the analytes in the new matrix. In this research the validation process included the evaluation of linearity, accuracy, precision, calculation of the limit of quantification (LOQ), uncertainty, and the study of the carryover and matrix effect. For most compounds included in this method, there is no specific guide for method validation. For veterinary drugs and considering liver as a food product of animal origin, the requirements for the methods and validation are presented in the UE’s Regulation 808/2021 [32]. Therefore, we decided to follow this regulation, and also the guide of Standard Practices for Method Validation in Forensic Toxicology (SWGTOX) [33], and the EU’s Directorate-General for Health and Food Safety analytical method validation guide (SANTE) [34].
The linearity of the response was studied by injecting blank liver extract samples spiked with all analytes at 11 levels (range 0.4–40 ng/g) and processed with the method described in Section 2.3 of this section, in quintuplicate. To determine accuracy and precision, % recovery (range 70–120% being acceptable, as specified in the guideline used) and % relative standard deviation (%RSD, values ≤ 20% being acceptable) were calculated, respectively. Recovery and RSD experiments were performed with blank liver samples fortified at least in five quintuplicate concentrations within the working range. For the calculation of the LOQ, matrix-matched calibration curves were prepared in quintuplicate (below 20 ng/g). From these, the lowest concentration level of each analyte that met the criteria for identification, accuracy and precision was considered as the LOQ. For confirmation of compound identity and selectivity, 2 MRM transitions were used, one for quantification (Q) and one for confirmation (q). A maximum deviation of ±30% was tolerated for the ion ratio [35]. Similarly, a maximum deviation of ±0.1 min was established for the retention time.

2.6. Samples for the Applicability of the Method

The main objective of this research is to demonstrate the applicability of the validated method in the two fields of application mentioned above: (a) verification of compliance with maximum residue limits in livers intended for human consumption; and (b) biomonitoring of contaminants in wildlife. For this purpose, a set of samples was collected for each of the two independent studies. The samples are described in the following subsections.

2.6.1. Sampling for the Food Safety Study

To verify the applicability of this method for the control of residues subject to MRLs in livers intended for human consumption, 46 liver samples from butcheries, supermarkets, and the general slaughterhouse of Gran Canaria were acquired: 34 samples of beef liver and 12 samples of chicken liver. All the samples, as they were acquired, were transferred to the laboratory and frozen at −20 °C until they were processed.

2.6.2. Sampling for the Biomonitoring Study

The validated method was applied to real samples of wildlife specimens that were received in our laboratory for forensic analyses in the period between September 2020 and May 2021. Thus, we studied a series of 151 fresh liver samples belonging to 15 different species of birds. All the specimens were sent by environmental agents or by the Tafira Fauna Rehabilitation Centre, within the framework of the Strategy for the Prevention and Control of Poisoning in the Canary Islands [36]. All the birds included in this part of the study died from different classes of trauma, and there was no suspicion that they died of poisoning. The species included in this study were: Accipiter nisus (n = 5); Ardea cinerea (n = 12); Asio otus canariensis (n = 34); Burrhinus oedicnemus (n = 10); Buteo buteo insularum (n = 12); Calonectris diomedea (n = 8); Ciconia ciconia (n = 2); Corvus corax canariensis (n = 16); Egretta garzetta (n = 4); Falco eleanorae (n = 2); Falco pelegrinoides (n = 6); Falco tinnunculus canariensis (n = 14); Larus michaellis (n = 14); Turdus merula (n = 4); and Tyto alba (n = 8). The livers, received or extracted at in situ necropsy, were kept at −24ºC until the moment of their processing for analysis. No animals were sacrificed for the purposes of this work.

2.7. Statistical Analyses

All statistical analyses were performed with GraphPad Prism v9.2 software (GraphPad Software, CA, USA). The distribution of the variables included in this study was evaluated using the Kolmogorov–Smirnov test. The concentration of most of the contaminants detected did not follow a normal distribution, so the results are expressed in terms of median and range. For this same reason nonparametric tests to check for statistical differences between groups were employed, as these evaluate the median rather than the mean, which is appropriate given the relatively high number of undetected values in some groups. Homogeneity of variance (homoscedasticity) was previously tested using Levene’s test. The Kruskal–Wallis and Mann–Whitney U tests were used as nonparametric tests for overall and pairwise comparisons, respectively. However, as an additional check, pairwise comparisons were also performed using Student’s t-test after logarithmic transformation of the data. A P-value of less than 0.05 (two-tailed) was considered statistically significant. The prevalence of exposure to each contaminant for each species was calculated as the percentage of animals with that residue detected in the liver over the total number of individuals of that species studied. For the study of determinants in the series used for biomonitoring, the response variables considered for comparisons were the amount in the liver of (a) the sum of non-persistent pesticides; (b) the sum of persistent organic pollutants; and (c) the sum of rodenticides.

3. Results and Discussion

3.1. Method Scope Extension Optimization

In our previous research we optimized and validated a multi-residue method for the analysis of 360 substances (pharmaceuticals, pesticides, rodenticides, and POPs) in blood for biomonitoring purposes [16,28]. Therefore, this is not an ex-novo methodological development, but an extension of the scope of our previously published method to include a new matrix, the liver. However, for a better method performance in this more complex matrix, we considered optimizing the previously established chromatographic conditions, including recalculation of RTs, as well as optimization of MRM transitions to allow for higher sensitivity, as well as adjusting qualifiers and qualifier ratios, and identifying possible interferences with matrix components. The compounds are shown in alphabetical order in Appendix A along with their retention time, transitions, and their collision energies. As we did with the original method in blood, we decided to directly inject the extracts obtained in acetonitrile for LC-MS/MS and GC-MS/MS analyses, without using evaporation and solvent change, to avoid the loss of the more volatile compounds. Several authors, including our group [30,37,38], have shown that ACN, although not the most commonly used solvent in GC-MS/MS, is an appropriate solvent for this type of analysis.
The final number of validated compounds in this scope extension counts 351 chemicals and metabolites compared to 360 in the previous work. With respect to the original method, there are 18 compounds that met the validation criteria in whole blood, which do not meet the validation criteria when the method is applied to liver samples: acetaminophen, chlorfenapyr, corticosterone 21 acetate, phenbutatin oxide, iprodione, isocarbophos, leptophos, malaoxon, malathion, marbofloxacin, methomyl oxime, N,N,-dimethyl-N-tolylsulfamide, paraoxon ethyl, parathion ethyl, penicillin G, phosmet oxon, piperacillin, and trichlorfon. On the other hand, the opposite occurred with 9 compounds. Dichlorvos, doramectin, metalaxyl, methiocarb-sulfoxide, moxidectin, oxime, pthalimide, pyrimicarb-desmethyl and spirotetramat met the validation criteria in the presence of liver matrix and could therefore be included in the method in liver, whereas in blood they did not and had to be left out.

3.2. Validation Parameters

For confirmation of compound identity and selectivity, 2 MRM transitions were used, one for quantification (Q) and one for confirmation (q). A maximum deviation of ±30% was tolerated for the ion ratio. Similarly, a maximum deviation of ±0.1 min was established for the retention time.
We first studied the linearity of the response by injecting blank liver extract samples spiked with all analytes at 11 levels (range 0.4–40 ng/g) and processed in quintuplicate with the method described in Section 2.3. The linearity study on the response (R2), indicated that this was higher than 0.98 for all analytes in the range studied.
To determine accuracy and precision, % recovery and % relative standard deviation (RSD) was calculated. A recovery within the range 70–120% and RSD values ≤ 20% was considered acceptable, as specified in the guidelines employed [33,34]. Recovery and RSD experiments were performed with blank liver samples fortified at least in four quintuplicate concentrations within the working range. The results of the recovery experiments are presented in Appendix B. Regarding accuracy and precision, most compounds meet the validation criteria for concentrations between their LOQ and the highest level studied (40 ng g−1). There were some exceptions where recoveries were outside the above range, especially at the lower concentrations. However, these cases are covered, both in the SANTE guideline and in the SWGTOX working document [33,34], which also accepts as a good validation criterion obtaining recoveries between 60% and 140% at some of the concentrations tested, provided that the RSD is less than 15%. Likewise, in some cases, the recoveries were within the established limits with an RSD slightly higher than 15%, a scenario that is also contemplated in the methodological guidelines, provided that the result is reproducible. As a rule, this second exception applies for concentrations equal to or lower than 4 ng g−1. As SANTE analytical guide recommends, the expanded measurement uncertainty (U’) was calculated, from precision and bias, and all analytes presented U’ < 50%, that complies with the requirement.
For the calculation of the LOQ, matrix-matched calibration curves were prepared in quintuplicate (0.2–20 ng g−1). From these, the lowest concentration level of each analyte that met the criteria for accuracy and precision was considered as the LOQ. As in the original method, the LOQ for the analytes included in this scope extension was calculated from five replicates of fortified blank matrix, within the working range. The lowest non-zero calibrator approximation was used to calculate LOQs. This means that the lowest point on the calibration curve that met the identity, bias, and precision criteria was established as the LOQ for a given compound. The LOQs for the 351 liver analytes are shown in Appendix B. The LOQ was set at 0.4 ng g−1 for 61 compounds, at 0.8 ng g−1 for 82 compounds, at 1.2 ng g−1 for 40 compounds, at 1.6 ng g−1 for 37 compounds, at 2 ng g−1 for 50 compounds, at 4 ng g−1 for 46 compounds, at 8.0 ng g−1 for 24 compounds, at 12 ng g−1 for 5 compounds, at 16 ng g−1 for 4 compounds, and at 20 ng g−1 for 2 compounds. That is, 76.9% of the compounds included in this method can be reliably and accurately quantified at concentrations below 2 ng g−1, making it suitable not only for food safety or poisoning diagnostic studies, but also for biomonitoring studies.
In the original method from which we started it was observed that there was a strong blood matrix effect on about 40% of the analytes. Presumably, a similar situation would occur with the liver matrix. Nevertheless, we decided to include the study of the matrix effect within the validation strategy of this analytical scope extension to prove it, as recommended in the reference guides. All validation assays involve the addition of known concentrations of analytes to the matrix. For the matrix effect study, we worked with the addition of three known concentrations of all analytes (2 ng g−1, 10 ng g−1, and 20 ng g−1) on blank liver extract, and the quantification was done against calibration curves prepared in solvent (without matrix). Experiments were performed in quintuplicate for each concentration. One difficulty was that, given the enormous number of substances included in the method, the liver was not completely free of 100% of the chemicals, in particular POPs. Therefore, in these cases, the response of the white matrix sample was subtracted from the calibration standards and QC to calculate the response of the externally added analyte. As we expected, matrix effect (ME) was observed for both, compounds analyzed by LC-MS/MS and GC-MS/MS, especially for compounds analyzed by the latter technique. A strong or medium suppression of the signal was demonstrated for 17.66% of the compounds (n = 62), and signal enhancement was verified for 36.47% of the compounds (n = 128). For the remaining 45.87% (n = 161 contaminants, the ME was considered negligible (−20% < M < 20%). Since for most of the compounds, significant ME was indeed observed, and it was concluded that matrix-matched calibration had to be used to compensate for these interferences. All detailed ME data for individual compounds in liver are shown in Appendix C.
Finally, we also assessed if carryover occurred after injecting a blank matrix fortified at 80 ng g−1 and processed with this method, before a blank matrix extract. We were not able to find a clear response in that blank matrix, so we concluded that in our working range, we had not any carryover effect in any of the analyzed compounds.

3.3. Application to Food Safety

In the study of the 34 beef liver samples, the results indicated the presence of a discrete number and concentration of contaminants, which ranged from 0 to 15 residues per sample, with an average of 3.13 residues. Of the 351 contaminants and metabolites included in the method, only 25 were detected in the total of beef liver samples, and of these 19 belong to the group of persistent or semi-persistent contaminants (4,4’-DDE, 4,4’-DDD, Dieldrin, Hexachlorobenzene, beta-hexachlorocyclohexane, BDE 153, PCB congeners #105, 118,126, 138, 155, 156, 157, 180, 189, naphthalene, phenanthrene, and pyrene). It is noteworthy that none of the concentrations in any of the samples exceeded the MRL, or even the value of half the MRL. In general, the concentrations of the contaminants detected were low, with the highest values being those of 4,4’-DDE, which was detected in 65.2% of the samples and with a median value of 92.2 ng g−1. The relatively high levels of DDT derivatives may seem surprising, as this substance was banned in Spain almost 5 decades ago. However, there is abundant literature that has documented that this pesticide was widely used in the Canary archipelago, and how this translates into the levels of this pesticide detected in food for human consumption produced in this region [39,40,41,42].
The next in frequency and concentration were PCB 153 (26.1%; 35.2 ng g−1) and PCB 138 (21.8%; 24.5 ng g−1). The other contaminants were detected in frequencies and concentrations much lower than these. Among the non-persistent pesticides detected in this series of consumption livers, very low levels of bifenthrin, fenazaquin, fluquinconazole, flutalonil, flutriafol, and imidacloprid were detected.
If the detection of residues in beef liver was low and of little toxicological relevance, it was even more so in chicken liver. In the 12 samples analyzed, we detected only four contaminants out of the 351 included in the method: fenpropidin, fenpropimorph, levamisole, and 4,4’ DDE. The latter was the more relevant, and it was only detected in three of the 12 livers analyzed and at a much lower concentration than that detected in beef liver (mean = 4.3 ng g−1).
Although it is not the main objective of this study, we made an estimate of the risk of exposure to these contaminants through liver consumption. The calculations were made according to the standard methodology that has been described previously [43], and in no case were the tolerable daily intake levels for these contaminants exceeded, mainly due to the low consumption of liver by the Spanish population (only 1 g/day for the total offal consumption) [44].

3.4. Application to Biomonitoring

Regarding biomonitoring of chemical substances, this method was applied to fresh livers obtained from 151 carcasses of 15 species of wild birds whose causes of death were not related to poisoning (mainly trauma). Table 1 shows the results for each of the species, limited to show only the 52 contaminants that were detected in the series. This represents that 15% of the contaminants included in the method were detected.
The mean value of the number of contaminants per sample was 17. The species with the greatest variety of residues detected was Asio otus (n = 41), followed by Falco tinnunculus (n = 27). In contrast, the species with the lowest number of liver contaminants were Turdus merula (n = 5) and Ciconia ciconia (n = 3). Figure 1 shows the LC-MS/MS and GC-MS/MS chromatograms of one of the birds in the series with the highest number of different contaminants (a long-eared owl).
The most frequently detected contaminant was 4,4’-DDE, which was detected in 138 birds (91.4%), followed by PCB 153, detected in 116 animals (76.8%), brodifacoum in 109 animals (72.2%), bromadiolone in 87 animals (57.6%), and dieldrin in 59 animals (39.1%). With respect to concentrations, the highest concentrations corresponded to enrofloxacin, clindamycin and meloxicam (Table 1). However, these values cannot be considered within the biomonitoring study, since they correspond to drugs used during the hospitalization of many of these animals. Therefore, high concentrations of these substances have been marked with an asterisk. However, other veterinary pharmaceuticals detected in some specimens, such as tetraconazole, metronidazole, or sulfathiazole, are not part of the treatment administered and should be considered contaminants. In general terms, the highest concentrations of contaminants corresponded to 4,4’-DDE in all species. Overall, in quantitative terms, the group of organochlorine pesticides was the most abundant (Figure 2), and the group of persistent and semi-persistent organic pollutants accounted for more than 92% of the total concentration of pollutants detected in the livers of wild birds sampled in the Canary Islands very recently (September 2020–May 2021). This reflects, once again, that contamination by these compounds, in particular organochlorine insecticides, is still very prevalent in the Canary Islands, as has been reported for wildlife in this region [28,45,46,47]. As indicated in the previous section, there is a large literature body documenting the high levels of contamination by organochlorine pesticides in this region [48,49,50], which also translates into high levels in the biota that inhabit the archipelago. There is a possibility that the high levels detected could also come from the neighboring African continent [51], but in this biomonitoring study this option is ruled out, since all the birds sampled for this pilot study are residents in the archipelago and not migratory birds.
With respect to non-persistent pollutants, several aspects should be highlighted. First, the high prevalence of second-generation anticoagulant rodenticides in wildlife’s liver is noteworthy. It was expected, as it has been described in many parts of the world [52,53,54] and recently in the Canary Islands [45,55,56]. However, the presence of at least one of these compounds in more than 80% of the birds studied is striking, even in non-predatory birds such as the blackbird (Turdus merula) or the common curlew (Burhinus oedicnemus), which would point to the fact that these compounds penetrate the trophic chain by several routes, probably including invertebrates, as suggested by other authors [57,58].
The result for carbofuran is also surprising, given that none of the birds studied had any suspicion of intoxication. However, this potent insecticide, banned in the EU since 2007 [59] was detected in small concentrations in the liver of 10 birds of the series, being higher in the case of canary crows (6/12 positives, median = 94.5 ng/g). In all these crows, the main carbofuran metabolite was also detected. This toxicant has widely affected wildlife worldwide [60,61,62,63] and in the Canary Islands its use has been extensive and also has affected wildlife in the past [64]. From the results of this study, it still is today, and it can be concluded that it even penetrates the trophic chain. With respect to the rest of the non-persistent compounds detected in this series, 2-phenylphenol (PHP) stands out. PHP was detected in eleven birds, including five common curlews (Table 1). PHP is a biocide used as a preservative and surface disinfectant on fibers and other materials in homes, hospitals, and elsewhere, and is recognized as a potential endocrine disruptor [65]. Other authors have also reported that PHP is a highly prevalent contaminant in biota samples, such as river fish of different species, where it is found in up to 100% of samples [66].
Since this was an opportunistic study on carcasses obtained from wildlife recovery centers, we did not have too many quality variables to carry out an in-depth study of the determinants of contamination patterns. Even so, we wanted to explore the influence of the variables inherent to the species studied and found a series of statistically significant differences. Thus, when we compared aquatic versus terrestrial birds, we found that the latter presented significantly higher levels of contamination by the three major chemical groups studied (Figure 3).
This result was expected with regard to rodenticides, since in a previous study by our group focused on these compounds, we had already discarded the group of waterfowl due to their low incidence in these pollutants [56]. Regarding POPs and non-persistent pesticides, although there is not much literature comparing both types of birds from the same region, the available studies usually indicate results similar to ours, with levels in landbirds usually being higher than in waterbirds [67,68,69].
Another variable that seems to influence the pattern of contamination is the raptor/predator bird status. The raptors in our study presented higher levels of POPs than non-predatory birds (Figure 4), which is logical given that they feed higher in the trophic chain, and has been described in the literature [68,69]. They also presented higher levels of AR, as we expected from having previously observed it in this region [56], and also described by other authors [70]. However, in the case of agricultural pesticides the statistical significance was the opposite, with non-predatory birds presenting the highest levels. There is not much literature to support this finding, but a recent study using the terrestrial pesticide residue exposure (T-REX) model estimated that the highest risk was presented by insectivorous birds, followed by fruit and seed feeders [71].
Finally, we also studied the influence of the diurnal/nocturnal habits of the birds in the study, and found that diurnal species have higher pesticide levels, but lower POPs and ARs than nocturnal species (Figure 5). We believe that the pesticide result has to do with the previous variable, in the sense that, in our study, all insectivorous species, and those that feed on fruits and seeds are diurnal, while the nocturnal birds in our series are both raptors that feed mainly on large and small rodents. For this same reason, and as we had already verified in previous studies, the nocturnal birds of the Canary Islands have higher levels of POPs [72] and AR [45,56].

4. Conclusions

The validated method allows the simultaneous analysis in liver of 351 substances (POPs, pesticides including rodenticides and drugs), using only 1 gram of sample. This is important, since in veterinary forensic medicine, especially with small animals, the amount of sample available is very limited. The proposed analytical method can detect trace amounts of all chemicals in the liver of multiple species. Therefore, it can be successfully applied and used as a routine method in environmental chemistry and forensic toxicology laboratories. The method we have developed can also be used in residue control studies in food intended for human consumption and for the purpose of food safety assessment.

Author Contributions

Conceptualization, C.R.-B. and O.P.L.; methodology, C.R.-B. and A.A.-D.; software, C.R.-B. and A.A.-D.; validation, C.R.-B., A.A.-D., A.M.-M., and Á.R.-H.; formal analysis, L.A.H.-H., C.R.-B. and O.P.L.; investigation, C.R.-B., A.A.-D., A.M.-M., Á.R.-H. and B.M.C.; resources, L.D.B. and O.P.L.; data curation, C.R.-B. and M.Z.; writing—original draft preparation, O.P.L., M.d.M.T.-A. and C.R.-B.; writing—review and editing, O.P.L., M.d.M.T.-A. and C.R.-B.; visualization, O.P.L.; supervision, O.P.L. and L.D.B.; project administration, O.P.L.; funding acquisition, O.P.L., M.Z., L.A.H.-H. and L.D.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the University of Las Palmas de Gran Canaria, grant number ULPGC-012-2016, to C. Rial-Berriel., and by the Spanish Ministry of Education, Culture and Sports, grant number FPU16-01888, to A. Acosta-Dacal.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

On request to the authors.

Conflicts of Interest

The authors declare no conflict of interest.

Appendix A

Table A1. Chromatographic and mass spectrometric conditions of the compounds analyzed in liver.
Table A1. Chromatographic and mass spectrometric conditions of the compounds analyzed in liver.
No.CompoundTechniqueRetention Time (min)PolarityQuantificationConfirmationFragmentor Voltage (V)
MRM (m/z)Collision energy (eV)MRM transition (m/z)Collision energy (eV)
12-PhenylphenolGC6.28positive169.0 → 115.030169.0 → 141.01570
24,4’-Dichlorobenzophenone (metabolite of dicofol)GC9.99positive250.0 → 139.015250.0 → 215.0570
3AbamectineLC10.99positive890.5 → 567.110895.5 → 751.445160
4AcenaphtheneGC6.15positive153.0 → 152.025153.0 → 151.03570
5AcenaphtyleneGC5.94positive152.0 → 151.025152.0 → 126.03070
6AcephateLC1.64positive184.0 → 143.015143.0 → 95.01570
7AcetamipridLC4.43positive223.1 → 126.027223.1 → 90.045140
8AcrinathrinLC10.70positive559.0 → 208.010559.0 → 181.03070
9AlbendazoleLC7.14positive266.1 → 234.116266.1 → 191.032155
10AldicarbLC5.11positive208.0 → 116.010116.0 → 89.14100
11Aldicarb-sulfoneLC3.21positive240.1 → 76.016223.1 → 86.11375
12Aldicarb-sulfoxideLC2.75positive207.1 → 131.910207.1 → 89.11086
13AldrinGC9.90positive255.0 → 220.025263.0 → 228.01070
14AnthraceneGC8.40positive178.0 → 176.035178.0 → 152.03070
15AtrazineLC6.73positive216.0 → 173.915216.0 → 103.830130
16Azinphos-methylLC7.27positive318.0 → 132.18340.0 → 160.01060
17AzoxystrobinLC7.59positive404.1 → 372.18404.1 → 344.124110
18BDE-28GC12.22positive406.0 → 246.020406.0 → 167.02570
19BDE-47GC14.31positive326.0 → 138.045484.0 →324.02570
20BDE-85GC17.08positive564.0 → 404.025566.0 → 406.02570
21BDE-99GC16.27positive566.0 → 406.025564.0 → 404.03070
22BDE-100GC15.85positive566.0 → 406.025564.0 → 404.02570
23BDE-153GC18.04positive644.0 → 484.025486.0 → 377.03070
24BDE-154GC17.47positive644.0 → 484.025486.0 → 377.03070
25BDE-183GC20.12positive561.6 → 454.740563.6 → 454.74070
26BenalaxylLC8.96positive326.2 → 148.020326.2 → 208.01290
27BendiocarbLC5.88positive224.1 → 166.98224.2 → 108.915120
28Bendiocarb metabolite (2,2-dimethylbenzo-1. 3-dioxol-4-ol)GC4.84positive166.0 → 151.010166.0 → 126.02070
29BenfuracarbLC9.73positive411.2 → 190.013411.2 → 252.015110
30Benzo[a]anthraceneGC13.95positive228.0 → 226.040228.0 → 202.03570
31Benzo[a]pyreneGC16.89positive252.0 → 250.045252.0 → 248.06070
32Benzo[b]fluorantheneGC16.30positive252.0 → 248.060252.0 → 226.03570
33Benzo[ghi]peryleneGC19.61positive276.0 → 274.050276.0 → 272.06070
34Benzo[k]fluorantheneGC16.29positive252.0 → 250.045252.0 → 224.04070
35BifenthrinGC11.25positive440.0 → 181.05440.0 → 165.06094
36BitertanolLC9.23positive338.2 → 70.04338.2 → 269.25100
37Boscalid (formerly nicobifen)GC7.84positive3434.0 → 272.030343.0 → 140.045100
38BrodifacoumLC10.78negative521.3 → 79.050523.3 → 135.045220
39BromadioloneLC9.75negative525.3 → 250.040527.3 → 250.040200
40BromopropylateGC13.87positive341.0 → 183.015341.0 → 157.04570
41Bromuconazole (two isomers)GC13.81/14.24positive295.0 → 173.010295.0 → 175.01070
42BupirimateLC11.78positive273.0 → 108.015273.0 → 193.0570
43BuprofezinLC9.83positive306.1 → 201.012306.1 → 116.012140
44Cadusafos (ebufos)LC9.39positive271.1 → 159.016271.1 → 131.022100
45CarbarylLC6.21positive202.1 → 145.14202.1 → 127.12895
46Carbendazim (azole)LC2.90positive192.1 → 160.14202.1 → 127.12890
47CarbofuranLC5.91positive222.1 → 123.120222.1 → 165.13080
48Carbofuran-3-hydroxyLC4.27positive238.1 → 163.110238.1 → 181.110110
49CarbosulfanLC11.03positive381.2 → 160.212381.2 → 76.136120
50Cefuroxima axetil (two isomers)LC5.13positive533.0 → 447.015533.0 → 386.020160
51ChloramphenicolLC4.63negative321.0 → 152.14323.0 → 152.14113
52ChlorantraniliproleLC7.32positive483.9 → 452.916483.9 → 285.98105
53ChlorfenvinphosLC9.09positive361.1 → 98.934358.9 → 155.18105
54ChlorobenzilateGC12.14positive251.0 → 111.040251.0 → 139.01570
55ChlorophacinoneLC8.88negative373.2 → 201.020375.2 → 203.020160
56ChlorprophamGC7.13positive213.0 → 127.015153.0 → 90.02570
57ChlorpyrifosGC9.93positive314.0 → 258.015314.0 → 286.0570
58Chlorpyrifos methylGC9.12positive286.0 → 93.025286.0 → 271.01570
59Chlorthal dimethylGC10.02positive300.9 → 166.955300.9 → 222.92570
60ChryseneGC13.86positive228.0 → 226.040228.0 → 227.02570
61ClindamycinLC5.33positive425.2 → 126.120425.2 → 377.220150
62ClofentezineLC9.19positive303.1 → 138.012303.1 → 102.040120
63ClothianidinLC3.91positive250.0 → 169.08250.0 → 131.98100
64CloxacillinLC6.86positive436.1 → 160.08436.1 → 277.012126
65CoumachlorLC8.63positive343.1 → 162.815342.1 → 285.015120
66CoumaphosLC8.98positive363.0 → 227.030363.0 → 306.915120
67CoumatetralylLC8.31negative291.1 → 141.030291.1 → 247.020140
68CyazofamidLC8.49positive325.0 → 108.020325.0 → 261.11590
69CyflufenamidLC9.18positive413.1 → 223.133413.1 → 295.12370
70Cyfluthrin (sum of four isomers)GC16.07/16.19/16.25/16.32positive226.0 → 206.025198.9 → 170.12570
71Cyhalothrin (lambda isomer)GC10.49positive181.1 → 152.110181.1 → 127.14670
72CymoxanilLC4.67positive199.1 → 128.04199.1 → 110.91290
73Cypermethrin (sum of four isomers)GC16.34/16.44/16.52/16.63positive163.0 → 109.020163.0 → 127.0570
74Cyproconazole (two isomers)GC11.98positive222.0 → 125.020222.0 → 82.01070
75CyprodinilLC8.46positive226.0 → 93.033226.0 → 10825100
76CyromazineLC1.23positive167.1 → 85.016167.1 → 125.020120
77DanofloxacinLC4.04positive358.2 → 340.120358.2 → 82.150159
78DazometGC7.80positive161.9 → 44.028161.9 → 89.0570
79DeltamethrinLC10.65positive523.0 → 281.010523.0 → 506.05100
80Demeton-S-methylLC5.97positive230.9 → 88.95230.9 → 61.03050
81Demeton-S-methyl-sulfone (Dioxydemeton)LC3.31positive263.0 → 169.024263.0 → 109.012120
82DexamethasoneLC7.16positive393.2 → 373.22393.2 → 355.26103
83DiazinonGC8.29positive137.1 → 54.020304.0 → 179.01570
84Dibenzo[a,h]anthraceneGC19.15positive278.0 → 276.040278.0 → 250.06070
85Dichlorodiphenyldichloroethane (p,p′ DDD)GC12.31positive235.0 → 165.020235.0 → 199.01570
86Dichlorodiphenyldichloroethylene (p,p′ DDE)GC11.58positive318.0 → 176.060318.0 → 248.03070
87Dichlorodiphenyltrichloroethane (p,p′ DDT)GC12.84positive235.0 → 165.040235.0 → 199.01570
88DiclofenacLC8.73positive296.0 → 215.116296.0 → 214.148103
89DicloranGC7.80positive206.0 → 176.010206.0 → 148.02570
90DiclorvosGC4.74positive184.9 → 93.010185.0 → 109.01570
91DicloxacillinLC7.24positive470.0 → 160.08470.0 → 310.810106
92DieldrinGC11.66positive263.0 → 228.015277.0 → 241.01570
93Diethathyl ethylLC8.71positive312.2 → 238.115312.2 → 162.030120
94DiethofencarbLC7.57positive268.2 → 226.15268.2 → 152.020110
95DifenacoumLC10.38negative443.2 → 135.040443.2 → 293.035200
96DifenoconazoleLC9.41positive406.1 → 250.928406.1 → 337.016176
97DifethialoneLC10.93negative537.3 → 79.050537.3 → 151.045220
98DifloxacinLC3.86positive400.2 → 382.120400.2 → 356.116149
99DiflubenzuronLC8.63positive311.0 → 158.08311.0 → 141.03290
100DiflufenicanGC13.27positive394.0 → 266.010266.0 → 246.01070
101Dimethenamid-P (and its R-isomer)LC7.68positive276.1 → 244.110276.1 → 168.120125
102DimethoateLC4.21positive230.0 → 125.016230.0 → 198.82070
103Dimethomorph (two isomers)LC7.86positive388.1 → 301.120388.1 → 165.132180
104Dimethylphenylsulfamide (DMSA. metabolite of dichlofluanid)LC5.21positive201.1 → 92.115201.1 → 137.15100
105Diniconazole-MLC9.34positive326.1 → 70.028328.1 → 70.028110
106DinocapLC10.51negative295.4 → 208.930295.4 → 193.035150
107DiphacinoneLC8.60negative339.1 → 167.025339.1 → 145.020170
108DiphenylamineGC6.98positive168.0 → 167.215169.0 → 66.01570
109DodineLC9.02positive228.3 → 43.040228.3 → 57.025150
110DoramectinaLC11.31positive921.5 → 777.455899.5 → 145.130220
111Endosulfan alfaGC11.21positive241.0 → 206.015195.0 → 160.01070
112Endosulfan betaGC12.21positive241.0 → 206.015195.0 → 159.01570
113Endosulfan sulfateGC12.96positive270.0 → 235.015387.0 → 289.0570
114EndrinGC12.05positive263.0 → 193.035245.0 → 173.02570
115EnrofloxacinLC3.94positive360.2 → 316.116360.2 → 245.128144
116EPNGC13.90positive157.0 → 63.010157.0 → 110.01570
117EpoxiconazoleLC8.47positive330.0 → 120.924330.1 → 100.950120
118EprinomectinLC10.84positive878.5 → 186.015936.5 → 490.460160
119EritromicinLC6.74positive734.5 → 158.132734.5 → 576.316172
120EsfenvalerateGC17.56positive167.1 → 125.115167.1 → 89.14570
121Ethion (diethion)LC10.03positive385.0 → 199.05385.0 → 171.010100
122EthirimolLC4.80positive210.2 → 140.120210.2 → 98.128160
123EthofumesateGC9.59positive286.0 → 207.05286.0 → 161.02070
124EthoprophosLC8.38positive243.1 → 97.030243.1 → 130.91590
125EtofenproxGC16.75positive163.0 → 107.020163.0 → 135.01070
126EtoxazoleLC10.34positive360.1 → 141.026360.1 → 304.016160
127FamoxadoneLC9.07positive392.1 → 330.95392.2 → 238.112110
128FenamidoneLC9.06positive392.1 → 330.95392.1 → 238.112110
129FenamiphosLC7.72positive304.1 → 217.120304.1 → 202.036120
130Fenamiphos sulfoneLC8.63positive336.1 → 188.031336.1 → 266.023120
131Fenamiphos sulfoxideLC5.93positive320.1 → 233.020320.1 → 108.144120
132FenarimolGC15.03positive139.0 → 75.030139.0 → 111.01570
133FenazaquinLC10.73positive307.2 → 57.125307.2 → 161.11690
134FenbendazoleLC8.04positive300.1 → 268.120300.1 → 159.036156
135FenbuconazoleGC16.17positive198.0 → 102.030198.0 → 78.03070
136FenhexamidLC8.35positive302.1 → 97.120302.1 → 55.140130
137FenitrothionGC9.57positive277.0 → 109.015277.0 → 125.01570
138FenoxycarbLC8.69positive302.1 → 88.020302.1 → 116.110110
139FenpropathrinLC10.43positive367.2 → 125.016350.1 → 125.01672
140FenpropidinLC7.13positive274.3 → 147.030274.3 → 86.025170
141FenpropimorphLC7.37positive304.3 → 147.130304.3 → 130.025120
142FenpyroximateLC10.49positive422.2 → 366.212422.2 → 135.036160
143FenthionGC8.90positive278.0 → 109.015278.0 → 125.02070
144Fenthion oxonLC7.31positive263.1 → 231.216263.1 → 216.024120
145Fenthion oxon sulfoneLC4.50positive295.0 → 217.015295.0 → 104.224110
146Fenthion oxon sulfoxideLC4.26positive279.0 → 264.220279.0 → 104.128110
147Fenthion sulfoneLC6.39positive311.0 → 125.022311.0 → 109.028140
148Fenthion sulfoxideLC6.16positive295.0 → 108.930295.0 → 280.018140
149FenvalerateGC17.36positive167.0 → 125.122167.0 → 89.03070
150FipronilLC8.68negative435.0 → 330.012435.0 → 249.926116
151Fipronil sulfideGC10.49positive351.0 → 255.020420.0 → 351.02570
152FlocoumafenLC10.44negative541.3 → 382.025541.3 → 161.040230
153FluazinamLC10.01negative462.9 → 416.010462.9 → 398.09140
154FlubendiamideLC8.82positive408.0 → 274.015408.0 → 256.030120
155Flucythrinate (two isomers)GC16.67/16.84positive156.9 → 107.115199.1 → 107.12570
156FludioxonilGC11.51positive248.0 → 127.030248.1 → 182.11070
157FlufenoxuronLC10.37positive489.1 → 158.020489.1 → 140.956110
158FlumequineLC6.12positive262.1 → 244.016262.1 → 202.032116
159FlunixinLC8.09positive297.1 → 279.124297.1 → 264.132141
160FluopyramGC10.61positive173.0 → 95.035223.0 → 196.04070
161FluorantheneGC10.66positive202.0 → 201.027202.0 → 152.04270
162FluoreneGC6.81positive165.0 → 163.040165.0 → 139.03070
163FluquinconazoleGC15.81positive340.0 → 298.015340.0 → 286.02570
164FlusilazoleLC8.64positive316.1 → 247.115316.1 → 165.020160
165FlutolanilLC7.93positive324.1 → 262.116324.1 → 242.124130
166FlutriafolGC11.26positive219.0 → 95.035219.0 → 123.01570
167Fluvalinate tauGC17.56positive250.1 → 55.130252.0 → 200.02070
168FonofosGC8.24positive246.0 → 109.015246.0 → 237.0570
169FormetanateLC1.76positive222.1 → 165.112222.1 → 46.228105
170FosthiazateLC6.50positive284.0 → 104.020284.0 → 227.8890
171HeptachlorGC9.31positive272.0 → 237.015274.0 → 239.01570
172HexachlorobenceneGC7.77positive284.0 → 214.040284.0 → 249.02570
173Hexachlorocyclohexane (alpha)GC7.64positive219.0 → 109.010219.0 → 183.01070
174Hexachlorocyclohexane (beta)GC8.02positive219.0 → 109.040219.0 → 183.0570
175Hexachlorocyclohexane (delta)GC8.50positive219.0 → 109.045219.0 → 183.0570
176Hexaclorocyclohexane (gamma. lindane)GC8.13positive291.0 → 109.040219.0 →183.01070
177Hexaconazole (two isomers)LC8.49positive314.1 → 70.120316.0 → 70.12095
178HexaflumuronLC9.58negative458.8 → 439.08458.8 → 175.030100
179HexythiazoxLC10.18positive353.1 → 227.98353.1 → 168.124120
180Imazalil (enilconazole)LC6.53positive297.1 → 159.020297.1 → 69.118100
181ImidaclopridLC3.93positive256.0 → 175.012256.0 → 209.012110
182Indeno [1,2,3-cd] pyreneGC19.08positive276.0 → 274.050276.0 → 272.06070
183IndoxacarbLC9.49positive528.1 → 293.110528.1 → 202.848140
184IprovalicarbLC8.18positive321.2 → 119.015321.2 → 202.920110
185Isofenphos methylGC10.38positive199.0 → 121.010241.0 → 121.02570
186IsoprothiolaneLC7.94positive291.1 → 189.030291.1 → 145.036100
187Ivermectin B1aLC11.52positive897.5 → 753.550897.5 → 329.360160
188JosamycinLC7.40positive860.5 → 173.940860.5 → 108.940200
189KetoprofenLC7.34positive255.1 → 209.18255.1 → 77.148123
190Kresoxim methylGC11.78positive116.0 → 89.015206.0 → 131.01070
191LevamisoleLC3.12positive205.1 → 178.120205.1 → 123.032141
192LincomycinLC3.50positive407.2 → 126.124407.2 → 359.216150
193LinuronLC7.54positive249.0 → 160.120249.0 → 182.38120
194LufenuronLC10.05negative509.0 → 339.05509.0 → 326.11590
195MandipropamidLC7.90positive412.1 → 328.18412.1 → 356.14130
196MebendazoleLC6.68positive296.1 → 264.120296.1 → 77.048151
197Mefenamic acidLC9.52positive242.1 → 209.128242.1 → 180.10108
198Mefenoxam (metalaxyl-M)LC6.95positive280.0 → 220.010280.0 → 192.015110
199MeloxicamLC7.17positive352.5 → 114.820352.5 → 140.820130
200MepanipyrimGC11.13positive222.0 → 221.015222.0 → 207.01570
201MepiquatLC0.64positive114.0 → 98.036114.0 → 70.045100
202MetaflumizoneLC9.94negative505.0 → 302.014541.0 → 302.02090
203MetalaxylGC9.31positive234.0 → 146.120249.0 → 146.02070
204MetaldehydeLC3.87positive194.1 → 61.95194.1 → 106.0550
205MetconazoleLC9.17positive320.1 → 70.233322.1 → 70.224250
206Methamidophos (two isomers)LC1.18positive142.0 → 94.012142.0 → 125.01285
207MethidathionLC7.12positive320.1 → 144.88320.1 → 85.03084
208MethiocarbLC7.67positive226.1 → 169.04226.1 → 121.11290
209Methiocarb-sufoneLC4.52positive258.1 → 201.18258.1 → 122.122100
210Methiocarb-sulfoxideLC4.03positive242.0 → 185.022242.0 → 122.02890
211MethomylLC3.23positive163.1 → 88.05163.0 → 106.0880
212MethoxyfenozideLC8.00positive369.2 → 149.010369.2 → 313.11585
213MetoxychlorGC13.98positive227.0 → 141.020227.0 → 169.01570
214MetrafenoneLC9.27positive409.1 → 209.18411.1 → 209.112108
215MetronidazoleLC2.63positive172.1 → 128.012172.1 → 82.12498
216Mevinphos (phosdrin)LC4.38positive225.0 → 193.115225.0 → 127.01265
217MirexGC5.66positive237.0 → 143.030274.0 → 237.01070
218MonocrotophosLC3.31positive224.1 → 126.812224.1 → 98.115100
219MoxidectinLC11.24positive641.4 → 529.25641.4 → 499.25100
220MyclobutanilLC8.10positive289.1 → 70.116289.1 → 125.132110
221N-(2,4-dimethylphenyl)-N′-methylformamidine (DMPF, metabolite of amitraz)LC3.35positive163.1 → 122.115163.1 → 107.115100
222N,N-Dimethyl-N′-p-tolylsulphamide (DMST, metabolite of tolyfluanid)LC6.06positive215.1 → 106.110215.1 → 151.1490
223NafcillinLC7.33positive415.0 → 199.18415.0 → 171.036103
224NaphtaleneGC4.45positive128.0 → 127.015128.0 → 102.02570
225NaproxenLC7.59positive231.0 → 185.010231.1 → 169.921120
226NitenpyramLC3.30positive271.1 → 56.136271.1 → 224.912100
227NovobiocinLC9.69positive613.2 → 218.110613.2 → 396.110150
228NuarimolGC13.27positive235.0 → 139.015235.0 → 111.04070
229OfuraceLC5.97positive282.0 → 159.920282.0 → 147.930100
230OmethoateLC2.80positive214.1 → 124.822214.1 → 183.05100
231OxadixylLC5.43positive279.1 → 219.25279.1 → 132.232110
232OxamylLC2.87positive237.1 → 72.012237.1 → 90.0570
233Oxamyl-oximeLC2.46positive163.3 → 115.210163.3 → 72.11070
234OxfendazoleLC5.61positive316.1 → 159.032316.1 → 191.116166
235Oxolinic acidLC5.04positive262.1 → 216.032262.1 → 160.036110
236Oxydemeton methylLC3.01positive247.0 → 169.012247.0 → 109.024100
237OxyfluorfenGC11.68positive252.0 → 146.040300.0 → 223.01570
238PaclobutrazolLC7.89positive294.1 → 70.116294.1 → 125.236115
239Parathion methylGC9.12positive263.0 → 109.015263.0 → 79.03070
240PCB 28GC9.01positive256.0 → 186.025256.0 → 151.05070
241PCB 52GC9.58positive292.0 → 222.025292.0 → 220.02570
242PCB 77GC11.73positive292.0 → 220.025292.0 → 222.02570
243PCB 81GC11.56positive292.0 → 220.025292.0 → 222.02570
244PCB 101GC11.08positive326.0 → 256.030328.0 → 256.03070
245PCB 105GC12.66positive326.0 → 256.030328.0 → 256.03070
246PCB 114GC12.38positive326.0 → 256.030328.0 → 256.03070
247PCB 118GC12.18positive326.0 → 256.030328.0 → 256.03070
248PCB 123GC12.10positive326.0 → 256.030328.0 → 256.03070
249PCB 126GC13.23positive326.0 → 256.030328.0 → 256.03070
250PCB 138GC13.07positive360.0 → 290.025360.0 → 288.02570
251PCB 153GC12.57positive360.0 → 290.025360.0 → 288.02570
252PCB 156GC13.96positive360.0 → 290.025360.0 → 288.02570
253PCB 157GC14.07positive360.0 → 290.025360.0 → 288.02570
254PCB 167GC13.55positive360.0 → 290.025360.0 → 288.02570
255PCB 169GC14.61positive360.0 → 290.025360.0 → 288.02570
256PCB 180GC14.25positive394.0 → 324.030394.0 → 322.03070
257PCB 189GC15.25positive394.0 → 324.030394.0 → 322.03070
258PenconazoleGC10.52positive248.0 → 157.030248.0 → 192.01570
259PencycuronLC9.33positive329.1 → 125.124329.1 → 217.912160
260PendimethalinGC10.49positive252.0 → 162.010252.0 → 191.0570
261Penicillin VLC6.47positive383.2 → 159.910383.2 → 113.940130
262PermethrinGC15.69positive183.0 → 128.015183.1 → 153.11570
263PhenanthreneGC8.40positive178.0 → 176.035178.0 → 152.02870
264PhenylbutazoneLC8.25positive309.2 → 160.220309.2 → 77.155140
265PhosaloneLC9.20positive385.1 → 182.020385.1 → 110.95580
266PhosmetLC7.34positive318.0 → 159.916318.0 → 133.04090
267Pthalamide (Folpet deg)GC5.94positive104.0 → 50.025147.0 → 76.02570
268PirimicarbLC5.11positive239.1 → 72.120239.1 → 182.112100
269Pirimicarb-desmethylLC3.71positive225.1 → 168.18225.1 → 72.120100
270Pirimiphos ethylGC10.26positive318.0 → 166.015318.0 → 182.01570
271Pirimiphos methylLC9.13positive306.1 → 164.020306.1 → 108.132100
272ProchlorazLC9.08positive376.0 → 308.010376.0 → 70.120100
273ProcymidoneGC10.80positive283.0 → 67.040283.0 → 68.02570
274ProfenofosLC9.75positive375.0 → 305.020373.0 → 303.020100
275PropamocarbLC2.85positive189.2 → 102.012189.2 → 144.08110
276PropargiteLC10.37positive368.2 → 231.14368.2 → 175.01288
277PropiconazoleLC9.01positive342.0 → 69.021342.0 → 159.03990
278PropoxurLC5.83positive210.1 → 168.135210.1 → 65.14070
279Propyzamide (pronamide)LC7.92positive256.1 → 190.016256.1 → 173.02590
280ProquinazidGC13.32positive288.0 → 245.015288.0 → 217.03070
281ProthioconazolGC11.85positive186.0 → 49.020186.0 → 53.02570
282ProthiophosGC11.45positive266.9 → 221.035162.0 → 63.13070
283PymetrozineLC2.74positive218.1 → 105.020218.1 → 78.052120
284PyraclostrobinLC9.15positive388.1 → 193.88388.1 → 163.128120
285PyrazophosLC9.22positive374.1 → 222.123374.1 → 194.032100
286PyreneGC11.13positive202.0 → 201.027202.0 → 200.04570
287PyridabenLC10.75positive365.2 → 309.08309.1 → 147.016168
288PyridaphenthionLC8.11positive341.0 → 189.022341.0 → 205.034100
289PyrimethanilGC8.27positive198.0 → 118.040198.0 → 158.02070
290PyriproxifenLC10.07positive322.2 → 96.012322.2 → 184.92480
291QuinalfosLC8.72positive299.1 → 96.930299.1 →147.120130
292QuinoxyfenLC10.13positive308.0 → 197.032308.2 → 161.855120
293RifampicinLC7.89positive823.5 → 791.415823.5 → 399.125160
294RotenoneLC8.64positive395.1 → 213.120395.1 → 192.125150
295RoxithromycinLC7.67positive838.5 → 158.140838.5 → 116.155200
296SarafloxacinLC4.16positive386.1 → 342.116386.1 → 299.128144
297SimazineLC5.81positive202.4 → 68.130202.4 → 68.120120
298Spinosad (two isomers)LC9.10/9.43positive732.4 → 142.022732.4 → 98.060130
299Spiramycin (two isomers)LC4.58/4.90positive439.1 → 101.120439.1 → 88.05070
300SpirodiclofenLC10.50positive411.1 → 71.215411.1 → 313.05110
301SpiromesifenLC10.27positive388.0 → 273.025273.0 → 187.015110
302SpirotetramatLC8.23positive374.2 → 302.212374.2 → 216.136150
303SpiroxamineLC7.55positive298.3 → 144.116298.3 → 100.132120
304StrychnineLC3.00/3.61positive335.1 → 184.045335.1 → 156.040105
305SulfacetamideLC2.13positive215.3 → 155.910215.3 → 92.02090
306SulfachloropiridacineLC3.77positive285.0 → 156.012285.0 → 92.128101
307SulfadiacineLC2.80positive251.0 → 92.028251.0 → 156.012111
308SulfadimetoxineLC4.81positive311.0 → 92.032311.0 → 156.016139
309SulfadoxineLC4.12positive311.1 → 92.032311.1 → 156.016126
310SulfameracineLC3.26positive265.0 → 92.028265.0 → 156.012126
311SulfametacineLC3.44positive279.1 → 186.012279.1 → 92.032134
312SulfametizoleLC3.37positive271.0 → 92.028271.0 → 155.98103
313SulfametoxazoleLC3.93positive254.0 → 92.028254.0 → 156.012111
314SulfametoxipiridacineLC3.45positive281.0 → 155.912281.0 → 92.128121
315SulfamonomethoxineLC4.11positive281.1 → 156.014281.1 → 92.132120
316SulfapyridineLC2.82positive250.0 → 156.012250.0 → 92.028126
317SulfaquinoxalineLC4.99positive301.0 → 156.012301.0 → 92.132159
318SulfatiazoleLC2.98positive256.0 → 92.028256.0 → 156.012106
319SulfisoxazoleLC4.12positive268.0 → 156.08268.0 → 92.124106
320TebuconazoleLC8.92positive308.2 → 70.222308.2 → 125.153120
321TebufenocideLC8.66positive353.1 → 132.922353.1 → 297.12090
322TebufenpyradLC9.88positive334.2 → 117.047334.2 → 145.037180
323TeflubenzuronLC10.01negative379.0 → 339.015379.0 → 196.025100
324TefluthrinGC8.42positive177.0 → 127.015177.0 → 87.01570
325Telodrin (isobenzan)GC10.14positive310.8 → 240.825310.8 → 274.8570
326TerbufosGC8.15positive231.0 → 97.020231.0 → 129.01570
327TerbuthylazineGC8.12positive214.0 → 104.020214.0 → 132.01070
328TetrachlorvinphosLC8.72positive367.0 → 127.016365.0 → 127.016110
329TetraconazoleGC10.04positive336.0 → 204.035336.0 → 218.02070
330TetradifonGC14.36positive158.9 → 111.020354.0 → 159.01070
331TetramethrinGC13.87positive164.0 → 77.030164.0 → 107.01570
332ThiabendazoleGC5.94positive201.0 → 174.015201.0 → 130.03070
333ThiaclopridLC4.80positive253.0 → 126.016253.0 → 90.040140
334ThiamethoxamLC3.59positive292.0 → 211.18292.0 → 132.02280
335Thiophanate methylLC5.87positive343.0 → 151.020343.0 → 93.04690
336Tolclofos methylGC9.21positive265.0 → 93.030265.0 → 220.02570
337Tolfenamic acidLC9.80negative260.0 → 216.18260.0 → 35.120108
338TriadimefonLC8.03positive294.1 → 69.320294.1 → 197.215100
339TriadimenolLC8.22positive296.1 → 70.010298.1 → 70.01080
340Triazophos (hostathion)LC8.18positive314.1 → 162.019314.1 → 118.935100
341TrifloxystrobinLC9.50positive409.1 → 186.012409.1 → 145.052110
342TriflumizoleLC9.53positive346.1 → 278.04345.9 → 73.01580
343TriflumuronLC9.19positive359.0 → 156.08359.0 → 139.032120
344TrifluralinGC7.27positive264.0 → 160.015306.0 → 264.0570
345TrimethoprimLC3.45positive291.2 → 123.024291.2 → 230.120162
346TriticonazoleLC8.38positive318.1 → 70.133320.1 → 70.116110
347TylmicosinLC5.52positive869.6 → 174.148869.6 → 696.444294
348TylosinLC6.76positive916.5 → 174.140916.5 → 772.428210
349VinclozolinGC9.10positive212.0 → 145.025212.0 → 109.05070
350WarfarinLC7.86negative307.1 → 161.120307.1 → 250.120140
351ZoxamideLC9.03positive336.0 → 187.125187.1 → 88.940200

Appendix B

Table A2. Method validation results: Limits of quantification (LOQ), percentage recoveries and relative standard deviation obtained from intraday and interday studies.
Table A2. Method validation results: Limits of quantification (LOQ), percentage recoveries and relative standard deviation obtained from intraday and interday studies.
0.4 ng/mL1 ng/mL4 ng/mL20 ng/mL40 ng/mL
Precision (RSD. %) Precision (RSD. %) Precision (RSD. %) Precision (RSD. %) Precision (RSD. %)
No.CompoundLOQ (ng/mL)Rec (%)IntradayInterdayRec. (%)IntradayInterdayRec. (%)IntradayInterdayRec. (%)IntradayInterdayRec. (%)IntradayInterday
12-Phenylphenol2 101.4319.6918.85107.1720.6619.28106.4718.2417.1396.4113.8114.32
24,4’-Dichlorobenzophenone (metabolite of dicofol)2 91.3613.2314.4886.9913.7915.85116.7711.7610.0798.3715.5915.85
3Abamectine4 106.4314.5313.6593.895.215.5599.4314.5014.58
4Acenaphthene1.2 110.8819.3919.2994.916.787.1496.4512.0812.5295.234.524.75
5Acenaphtylene2 107.0618.9021.3995.7412.5313.09100.5012.2612.2098.402.932.98
6Acephate8 90.7520.1522.2093.2414.9616.04
7Acetamiprid2 122.138.036.57101.2614.2114.03104.424.704.50104.714.764.55
8Acrinathrin4 116.0816.7314.41103.1122.1921.52104.555.455.21
9Albendazole0.4121.0311.399.4192.566.356.8686.9212.4814.3699.533.663.68105.104.304.09
10Aldicarb0.8119.2013.2510.2697.227.437.6489.9214.7016.35100.154.244.23107.895.244.86
11Aldicarb-sulfone2 121.8418.5115.1994.8416.9019.9185.7712.9115.0597.2610.1310.42
12Aldicarb-sulfoxide4 104.8218.4217.1181.915.977.29105.2612.1911.58
13Aldrin2 123.6619.1115.4591.5915.2516.65106.545.585.2497.3312.1212.45
14Anthracene1.6 99.6715.3515.4091.4715.4716.91105.347.326.9594.686.506.87
15Atrazine0.8124.534.213.3893.047.017.5387.6013.2315.10102.495.465.33110.166.626.01
16Azinphos-methyl2 126.8518.7414.77103.9813.7513.22105.193.503.33102.895.445.29
17Azoxystrobin0.4116.287.946.8395.413.964.1592.316.036.53102.954.524.39101.822.112.07
18BDE-281.2 100.5314.1914.1281.659.7811.98104.456.205.9496.6211.5111.91
19BDE-470.898.7120.3120.58109.4521.8719.9889.888.169.08110.248.747.9395.968.899.26
20BDE-850.8100.7715.7915.59103.1016.6516.1585.6112.9915.17108.2316.0914.8798.5117.9113.96
21BDE-990.4107.5418.5519.69103.7415.0214.4889.6512.6614.12114.0518.0015.7890.9711.9713.16
22BDE-1000.898.1521.9422.35106.7217.5421.8193.7110.6011.31109.9812.8011.6494.0519.8021.05
23BDE-1530.893.5816.9519.48108.6617.0419.8893.6515.2616.29111.4015.4413.8696.1117.1617.85
24BDE-1540.496.1915.7916.42113.5719.8417.4792.4310.7111.59118.1516.3413.8393.4213.9315.62
25BDE-1834 78.465.927.55104.6812.9012.3295.998.739.09
26Benalaxyl0.4116.6715.0612.9194.563.533.7397.646.316.46101.103.373.33101.393.012.97
27Bendiocarb0.8123.809.467.2990.1114.6516.2693.2314.2615.30101.723.103.05110.768.938.06
28Bendiocarb metabolite (2,2-dimethylbenzo-1. 3-dioxol-4-ol)4 86.8616.1421.61102.8216.7216.2695.653.053.19
29Benfuracarb0.8121.436.425.2488.0912.0513.6885.509.4811.0999.934.454.45102.765.965.80
30Benzo[a]anthracene0.898.9019.3819.7197.898.008.1785.044.755.59109.7314.4413.16101.0811.1010.98
31Benzo[a]pyrene0.8118.0119.7820.6694.1010.7411.4190.359.5310.55106.0111.7511.0898.1614.1714.44
32Benzo[b]fluoranthene1.2 101.2811.8911.6191.6210.1111.03105.118.027.6393.838.809.38
33Benzo[ghi]perylene0.880.1619.3220.41100.3515.4315.3893.479.3710.02114.396.355.5595.5010.8011.31
34Benzo[k]fluoranthene1.2 102.6613.2412.9088.8414.6316.47101.907.877.7299.4417.3217.42
35Bifenthrin2 118.6318.9319.1086.1714.0816.34113.5316.8314.8298.9910.0410.14
36Bitertanol0.4121.4123.3418.6184.3514.3116.9780.6910.7413.3199.714.764.77105.112.051.95
37Boscalid (formerly nicobifen)0.874.9622.4322.8185.765.166.0285.679.7811.42112.156.665.9489.338.339.32
38Brodifacoum0.4102.4423.5723.0188.9913.6715.3685.8412.9915.1390.415.616.21107.516.876.39
39Bromadiolone0.4118.1311.1319.8297.1120.5519.1989.4613.1314.6897.668.859.06101.308.878.76
40Bromopropylate0.4110.8321.1522.8696.3719.8520.6093.298.218.80107.2510.029.3496.5310.6711.05
41Bromuconazole (two isomers)1.6 106.7016.6314.9689.4817.1919.21112.7513.0811.6094.548.058.51
42Bupirimate1.2 86.7710.7412.3893.945.746.1198.536.036.12102.434.994.87
43Buprofezin0.4115.8911.189.6593.221.922.0688.5710.6412.01101.634.504.43102.683.543.45
44Cadusafos (ebufos)0.4126.813.482.7494.264.044.2996.815.745.93101.635.004.92100.583.043.02
45Carbaryl0.8118.8413.5610.5296.236.276.5287.8111.2612.82100.434.374.35108.804.343.99
46Carbendazim (azole)2 120.178.976.4098.209.8310.01100.392.722.71103.563.813.68
47Carbofuran0.4123.8810.748.6794.306.426.8188.1413.5415.36104.416.506.23105.573.333.15
48Carbofuran-3-hydroxy0.8120.9810.768.8989.048.109.1094.4615.4116.31100.863.613.58107.554.884.54
49Carbosulfan1.2 109.1614.8719.1989.2921.2220.6292.1922.1223.9996.5721.0221.77
50Cefuroxima axetil (two isomers)4 132.3313.5110.21119.808.737.29127.0813.9811.00
51Chloramphenicol16 98.917.747.83
52Chlorantraniliprole16 106.002.932.76
53Chlorfenvinphos0.8114.2816.1014.0997.1414.6115.0491.5615.9617.43104.402.642.53106.323.783.56
54Chlorobenzilate1.6 110.4717.9316.2389.894.224.69114.6012.6611.0590.712.943.24
55Chlorophacinone8 98.4021.8422.3699.288.318.37
56Chlorpropham2 119.3917.6113.1393.1114.3915.45112.936.105.40100.1121.5621.54
57Chlorpyrifos1.6 74.8117.1719.3292.211.741.89119.549.958.3290.506.877.59
58Chlorpyrifos methyl2 115.2417.6314.9888.0815.5619.0290.859.9710.97106.306.986.57
59Chlorthal dimethyl0.8104.3817.2519.4396.7214.5515.0491.376.537.15113.909.828.6290.343.664.05
60Chrysene1.6 109.9112.4211.3091.837.037.66106.1017.0616.08100.2511.3411.31
61Clindamycin4 129.2510.538.15109.207.446.81107.366.375.93
62Clofentezine0.8116.8020.5917.6394.997.998.4183.6611.1813.3696.747.457.70105.684.564.31
63Clothianidin12 105.528.638.1897.8811.4411.69
64Cloxacillin8 99.3318.2718.39107.7910.049.31
65Coumachlor0.8120.8516.8520.8499.9012.1412.1585.4816.0618.79101.574.204.14102.892.202.14
66Coumaphos0.8112.5914.0312.4686.2415.3417.7986.4910.7112.38105.364.203.99103.384.364.22
67Coumatetralyl1.6 116.1222.6219.4897.659.9810.2296.874.294.43102.714.394.27
68Cyazofamid2 112.2613.6612.17100.2912.0612.03103.987.086.8197.875.045.15
69Cyflufenamid1.6 116.7517.9723.9696.0219.4420.2598.166.897.02105.147.867.48
70Cyfluthrin (sum of four isomers)8 128.3319.8215.4487.9419.5121.60
71Cyhalothrin (lambda isomer)4 118.4517.5814.84110.3618.5416.80102.1514.5214.21
72Cymoxanil2 127.9823.2018.13112.7813.1411.65111.183.172.85107.247.196.70
73Cypermethrin (sum of four isomers)20 125.4215.6412.4774.3110.1813.70
74Cyproconazole (two isomers)4 120.6619.7320.0189.9815.5117.24110.685.935.3693.417.337.85
75Cyprodinil1.2 110.9113.6912.3489.7215.2517.0097.148.228.46104.227.417.11
76Cyromazine8 94.5811.2911.9496.7411.3211.70
77Danofloxacin8 113.5518.3016.1289.7610.3911.58
78Dazomet4 71.5317.5521.5083.0313.8416.6790.8216.9518.66
79Deltamethrin4 95.8917.7419.36107.2818.6117.24100.6112.2812.21
80Demeton-S-methyl0.8123.359.937.7495.673.323.4787.3812.6414.47101.005.185.13108.476.185.70
81Demeton-S-methyl-sulfone (Dioxydemeton)12 80.244.836.0296.536.346.57
82Dexamethasone2 123.7917.6712.29104.6113.9313.32106.5314.4813.59102.964.324.20
83Diazinon1.2 101.7819.0518.6897.768.048.22110.6315.0313.5992.167.398.02
84Dibenzo[a.h]anthracene0.870.3918.6816.54112.5016.6214.7793.0611.7312.60111.294.834.3484.416.547.75
85Dichlorodiphenyldichloroethane (p,p′ DDD)0.888.2719.4217.67112.256.365.6792.5711.0311.92101.426.075.9993.464.775.10
86Dichlorodiphenyldichloroethylene (p,p′ DDE)0.899.7118.3918.44110.5617.8518.6797.627.467.64104.290.720.6998.408.588.72
87Dichlorodiphenyltrichloroethane (p,p′ DDT)2 101.8715.9814.95104.6520.6319.71110.436.325.7292.276.867.43
88Diclofenac4 111.2521.7119.5191.0312.4813.7194.4412.4213.15
89Dicloran4 95.6814.3815.03113.1715.8914.0492.285.095.52
90Diclorvos8 113.4810.389.1598.102.983.04
91Dicloxacillin12 77.5412.3515.93103.3510.6310.29
92Dieldrin8 80.7018.4018.4395.085.856.15
93Diethathyl ethyl0.4113.2612.8320.1696.1513.1713.7089.8415.2416.9697.956.166.2999.307.457.50
94Diethofencarb0.4113.986.385.6090.653.944.3590.8010.9012.00101.241.481.46104.261.971.89
95Difenacoum0.8117.6613.8421.5188.2710.3611.7485.407.729.0492.196.146.66104.373.773.61
96Difenoconazole0.8119.7817.9813.8594.458.839.3584.087.729.1897.086.456.64106.474.123.87
97Difethialone1.6 112.4410.799.6088.1018.2220.6895.866.456.73103.228.668.39
98Difloxacin4 123.3619.3415.68102.878.838.5899.178.548.61
99Diflubenzuron1.6 121.0316.6118.9899.7316.5416.58102.8617.0116.54105.634.133.91
100Diflufenican0.4114.3918.2419.49101.569.389.2495.899.5910.00115.498.357.2395.629.059.46
101Dimethenamid-P (and its R-isomer)0.4112.7315.6312.7487.824.745.4090.218.859.81103.643.953.81102.495.024.90
102Dimethoate0.8121.8320.2215.5793.115.475.8787.0511.8913.66100.0710.4010.39108.517.396.81
103Dimethomorph (two isomers)0.4123.3718.6815.1487.726.327.2087.2411.2912.94104.934.634.41105.805.875.55
104Dimethylphenylsulfamide (DMSA, metabolite of dichlofluanid)4 114.0511.5510.13109.559.658.81102.374.334.23
105Diniconazole-M1.2 97.8016.5216.8988.786.857.72102.7514.5414.15100.665.865.82
106Dinocap4 115.1916.4014.24105.542.902.75105.885.855.53
107Diphacinone8 96.7418.1118.72103.6619.5918.90
108Diphenylamine1.6 92.8120.6413.0196.185.325.53106.1110.459.8593.912.442.60
109Dodine0.8107.1912.6311.7897.648.188.3887.2610.4712.00102.275.325.20102.464.264.16
110Doramectina8 101.0419.6319.4399.139.039.11
111Endosulfan alfa2 112.4511.7310.4384.2219.4723.12122.5720.3420.7596.3510.2410.63
112Endosulfan beta4 85.3623.8119.45115.993.803.2888.359.6410.91
113Endosulfan sulfate4 70.4820.3018.80116.2119.5420.3289.1417.9320.11
114Endrin4 88.9617.6822.54107.5712.6611.7792.6912.7313.73
115Enrofloxacin4 118.6921.0219.5498.467.067.17104.3811.6411.15
116EPN2 81.3417.8919.1087.1222.9019.18112.3012.9711.5595.565.505.76
117Epoxiconazole0.8122.9816.5913.4989.4411.4313.9697.2119.3417.51106.2012.4911.76106.315.685.34
118Eprinomectin1.2 100.0321.3621.3589.9619.0721.2095.5710.1810.65102.438.658.44
119Eritromicin0.8122.8510.107.96101.217.597.5087.188.009.1893.376.336.78104.423.743.58
120Esfenvalerate2 127.5421.5816.92105.9119.4917.83101.514.204.1490.247.458.26
121Ethion (diethion)0.8109.217.326.7092.197.998.6789.528.279.2498.502.632.67100.663.503.48
122Ethirimol1.2 103.8013.9113.4084.858.4910.0198.866.546.62109.685.384.91
123Ethofumesate2 126.9715.4116.4890.7215.4821.11103.9913.9113.3896.268.989.33
124Ethoprophos0.8121.5817.9022.9585.9523.6317.4996.7913.4213.87103.334.564.41108.448.968.26
125Etofenprox1.2 103.0520.3519.7588.0012.8814.6487.544.705.37107.438.427.84
126Etoxazole0.4116.447.266.2395.395.736.0188.695.005.6498.791.961.9899.614.044.06
127Famoxadone1.2 105.5021.9119.8084.938.099.53100.068.508.49105.608.628.16
128Fenamidone0.4120.9711.079.1596.957.868.1190.0012.5213.91102.363.513.43105.445.425.14
129Fenamiphos0.4108.3019.3526.3396.2310.3710.7891.065.886.46102.966.586.39104.254.704.51
130Fenamiphos sulfone1.2 94.2518.8219.9793.809.169.77102.1810.5810.35112.343.883.45
131Fenamiphos sulfoxide1.2 89.3410.6711.9498.2610.6110.8099.745.765.78112.662.191.94
132Fenarimol1.6 100.3412.8112.7799.767.717.73109.446.215.6794.111.401.49
133Fenazaquin0.4120.2017.5714.6291.493.553.8882.119.3511.39100.132.892.89101.083.403.36
134Fenbendazole0.4120.7722.3217.0798.079.369.5484.8812.3214.5199.378.888.94105.255.154.89
135Fenbuconazole0.8117.3316.4717.9780.7015.6519.3992.4023.5615.50101.069.409.30104.915.735.46
136Fenhexamid4 113.7816.3417.33102.527.166.9896.729.7710.10
137Fenitrothion4 92.5817.8621.7791.3111.6612.7797.216.006.17
138Fenoxycarb0.4105.6117.4016.4894.0012.1812.9687.036.887.91101.053.543.5099.096.546.60
139Fenpropathrin0.8121.0618.9523.9181.9011.1513.6185.7210.1611.8596.223.833.98103.495.205.02
140Fenpropidin0.4118.5711.799.9488.818.309.3590.983.243.56100.276.866.84102.942.051.99
141Fenpropimorph0.8118.7913.4111.2985.4210.6112.4289.458.559.56101.398.158.04103.064.184.06
142Fenpyroximate0.4112.816.876.0994.833.343.5291.944.154.5197.901.861.90102.425.375.24
143Fenthion0.897.1714.2526.12109.2812.0010.9890.095.656.27114.7215.8813.8487.334.284.90
144Fenthion oxon0.4112.2710.399.2593.674.795.1187.288.709.97102.195.745.62105.283.243.08
145Fenthion oxon sulfone8 119.941.821.52105.666.015.69
146Fenthion oxon sulfoxide1.2 104.0510.4110.0088.9711.8513.32101.425.205.13107.054.904.58
147Fenthion sulfone1.6 111.178.938.0395.3019.7920.77105.0010.119.63105.576.325.99
148Fenthion sulfoxide1.6 115.5918.2015.7593.3612.6913.59104.116.726.45105.765.545.24
149Fenvalerate2 107.1718.7019.8588.712.412.72133.748.816.5989.169.1210.23
150Fipronil0.8102.0911.7211.4894.2319.3219.5693.248.749.3797.936.416.55101.302.102.07
151Fipronil sulfide8 99.2516.9517.08101.3110.4810.34
152Flocoumafen0.4106.8217.5016.3894.937.638.0484.008.5510.18101.023.523.48102.483.213.13
153Fluazinam2 80.6418.3122.36131.4319.4314.55125.265.6014.7184.1214.1216.79
154Flubendiamide1.6 114.3515.2113.3090.4115.1316.73100.9410.2610.1697.918.979.16
155Flucythrinate (two isomers)2 94.8914.7015.49103.0412.9019.51126.9910.328.1389.105.706.40
156Fludioxonil2 108.9422.5219.8588.579.1910.38112.876.355.6398.267.707.84
157Flufenoxuron0.8118.7420.7717.4990.496.246.9083.455.816.96100.225.175.16102.525.235.10
158Flumequine0.8127.047.725.6391.697.337.9990.229.1210.1195.006.526.86104.994.544.32
159Flunixin0.8123.198.486.8899.8018.4018.4486.2512.6114.6293.815.625.99103.218.758.48
160Fluopyram0.8123.1322.8318.5493.3713.6915.3783.3112.5915.11101.204.184.13105.165.275.01
161Fluoranthene2 119.5815.2417.0898.3812.5512.76101.894.524.44104.2616.8416.15
162Fluorene1.2 118.5418.9821.0788.324.324.8998.394.294.3696.272.062.14
163Fluquinconazole1.2 110.5516.6618.7486.386.857.93100.0112.0812.0881.407.909.71
164Flusilazole0.8108.7810.9810.0999.5310.4910.5488.088.549.70104.2212.2911.79102.064.154.07
165Flutolanil0.8117.1316.4014.0099.0310.0710.1790.6512.5113.80100.143.123.12102.557.517.32
166Flutriafol1.2 102.189.659.4491.7013.1514.34103.288.348.08106.174.424.16
167Fluvalinate tau4 78.5818.5423.5999.6518.4018.46105.6817.5416.60
168Fonofos1.6 96.7320.4622.4582.5410.9713.29115.9810.459.0190.584.374.82
169Formetanate1.2 105.8011.3310.7191.025.726.2890.927.257.97102.256.836.68
170Fosthiazate0.4117.5312.7610.8691.815.806.3289.9611.0012.23101.325.034.96103.762.061.99
171Heptachlor1.2 105.6313.9413.2095.6811.6612.19109.437.977.2891.443.653.99
172Hexachlorobencene0.898.4517.4318.64107.1020.8720.3587.604.825.50101.479.949.8090.602.382.63
173Hexachlorocyclohexane (alpha)2 117.5412.128.2188.985.416.08103.029.899.6092.168.258.95
174Hexachlorocyclohexane (beta)2 126.0417.4713.8697.433.533.62108.188.427.7893.188.519.13
175Hexachlorocyclohexane (delta)4 90.1519.0620.45104.7416.2215.4995.2211.9412.54
176Hexaclorocyclohexane (gamma, lindane)4 93.7514.1523.24107.486.806.3395.8212.9513.51
177Hexaconazole (two isomers)1.6 95.1915.0815.8491.807.628.30102.655.705.55103.192.942.85
178Hexaflumuron1.2 99.4117.9118.0280.355.757.1698.144.074.1598.7511.1011.24
179Hexythiazox0.4118.5517.8818.4682.228.5310.3787.629.3910.7298.622.882.92104.628.247.88
180Imazalil (enilconazole)0.8130.9215.4917.1895.757.748.0889.579.7410.87100.824.013.98104.515.194.97
181Imidacloprid4 117.555.494.67107.188.377.81102.448.248.04
182Indeno [1,2,3-cd] pyrene1.6 117.8915.4813.13116.3514.8712.78116.4517.2514.81100.1819.5419.50
183Indoxacarb0.8124.6114.8718.7099.0121.6521.8788.9817.7819.9893.096.877.38109.785.444.96
184Iprovalicarb0.8115.2010.979.5293.147.558.1189.116.567.36103.805.495.29102.293.923.83
185Isofenphos methyl2 126.1113.7510.9096.559.279.60112.125.554.9596.129.6810.07
186Isoprothiolane0.4106.893.333.1296.3218.0518.7492.8612.4613.42101.232.172.14102.114.864.76
187Ivermectin B1a1.6 113.4116.8914.8998.118.638.8091.7411.9112.98101.6310.5910.42
188Josamycin1.6 127.2118.8514.82103.075.895.7194.947.077.45108.512.462.27
189Ketoprofen1.6 93.4317.8419.09106.3915.5914.0595.6410.2010.66102.803.503.40
190Kresoxim methyl2 119.3419.8318.7298.0218.0918.66110.8814.0312.6596.6212.8513.30
191Levamisole1.6 114.2622.0719.3292.628.409.0786.677.088.17101.936.166.04
192Lincomycin4 120.6919.6416.27112.237.046.2796.556.396.62
193Linuron1.6 125.6415.5918.3389.8713.7715.3298.095.135.23107.805.054.68
194Lufenuron0.8112.8816.4214.5597.3213.8214.4878.0611.5014.73102.8110.9110.61102.874.154.03
195Mandipropamid0.4110.1914.6813.3291.627.618.3191.888.218.94103.644.694.53104.433.293.15
196Mebendazole0.4128.4110.288.0192.656.206.6986.9010.2311.7795.397.838.21104.162.752.64
197Mefenamic acid1.6 123.9717.9514.48102.5118.7718.3192.9113.7814.83102.923.833.72
198Mefenoxam (metalaxyl-M)0.4119.2210.178.5393.636.266.6991.6310.0811.00101.706.186.08103.382.082.01
199Meloxicam1.2 94.2717.5518.6689.5117.8916.5490.457.818.63106.5510.6510.00
200Mepanipyrim2 114.7120.0217.4592.366.477.01105.728.417.95102.762.902.82
201Mepiquat0.488.7515.7218.9896.6919.9620.6484.9517.7520.8992.247.488.11101.872.682.63
202Metaflumizone0.4120.696.985.7890.7210.1111.1487.978.189.30100.906.186.12101.693.743.68
203Metalaxyl1.6 102.248.988.7887.836.497.39114.5616.9214.7788.615.546.25
204Metaldehyde4 117.1816.4516.5282.8510.4812.65100.368.698.66
205Metconazole0.8126.928.056.3491.6213.2614.4785.8713.9316.2298.862.292.32104.834.734.51
206Methamidophos (two isomers)8 90.0812.3313.6995.627.097.41
207Methidathion0.4121.6311.909.7894.816.867.2492.1011.6012.60101.702.152.11105.467.136.76
208Methiocarb0.4126.5712.259.6882.567.769.4096.7410.4210.77106.925.785.41109.287.126.52
209Methiocarb-sufone2 124.4419.0520.07110.419.038.18106.557.797.31105.179.438.97
210Methiocarb-sulfoxide1.2 97.9011.9012.1697.4519.1319.63102.575.805.65107.535.475.09
211Methomyl1.2 105.7612.2811.61116.2918.7016.08114.173.663.21106.037.487.05
212Methoxyfenozide0.4 86.6321.8823.34102.2915.5315.1897.409.549.79
213Metoxychlor4116.968.597.3488.757.338.2690.853.704.07102.213.913.83102.303.363.28
214Metrafenone0.4126.2220.2116.0198.2213.2613.5085.597.198.4095.316.556.87107.705.475.08
215Metronidazole12 77.8519.3222.6394.468.549.04
216Mevinphos (phosdrin)1.2 107.1419.4318.1487.219.7011.1299.516.936.96112.134.494.00
217Mirex4 87.3015.8716.6399.7522.3322.39104.4312.5512.02
218Monocrotophos4 113.288.747.7299.083.053.08103.674.464.30
219Moxidectin4 97.0517.4619.8197.1519.0519.61101.687.427.30
220Myclobutanil0.8104.8319.5319.3199.6913.2313.2787.8210.5612.02102.169.439.23104.533.523.37
221N-(2.4-dimethylphenyl)-N′-methylformamidine (DMPF, metabolite of amitraz)4 112.0315.2213.5998.347.948.07102.655.615.47
222N.N-Dimethyl-N’-p-tolylsulphamide (DMST, metabolite of tolyfluanid)4 115.309.047.84106.194.774.49106.163.583.37
223Nafcillin4 106.6119.0517.8795.4811.5212.0798.704.024.07
224Naphtalene1.6 82.8715.6717.47114.4617.9814.45106.5118.6117.4796.496.526.76
225Naproxen2 128.2818.4116.21112.222.1518.76113.7519.6017.23102.626.866.68
226Nitenpyram8 109.6219.5517.83100.705.775.73
227Novobiocin1.2 96.8720.4019.1985.9818.6621.7089.4313.6715.2995.397.938.31
228Nuarimol1.2 106.9817.3015.5292.467.788.41122.9410.788.7789.255.476.13
229Ofurace0.8118.8720.456.6293.5018.1719.4388.509.6010.8594.994.064.27110.234.444.03
230Omethoate2 106.7814.8513.9197.8617.2517.6387.656.697.63105.0713.1712.53
231Oxadixyl0.8123.6118.9115.3097.194.294.4185.777.128.3098.575.695.77106.262.502.35
232Oxamyl8 107.5018.1416.87110.1621.8719.85
233Oxamyl-oxime8 99.1910.9211.0180.819.5711.8493.8610.6511.35
234Oxfendazole0.8132.5717.2513.01100.863.403.3790.0113.0814.5395.729.309.72105.182.021.92
235Oxolinic acid0.8 110.6210.569.5593.326.537.00101.825.024.93
236Oxydemeton methyl4125.2611.578.95103.936.926.6690.2115.1316.7794.206.156.53103.584.774.61
237Oxyfluorfen4 87.6918.0321.96104.7111.4310.9297.0114.1814.62
238Paclobutrazol1.6 115.255.875.0997.9810.8511.07103.315.225.05103.502.432.35
239Parathion methyl8 109.4918.4016.8187.753.954.50
240PCB 280.4109.0417.3521.35109.7910.369.4489.675.776.43103.246.025.8394.177.167.60
241PCB 520.8109.2910.869.94108.9814.5722.5583.4013.1415.76104.7510.459.98100.998.148.06
242PCB 770.893.4620.0915.7999.7220.8520.9199.9610.5710.57103.807.397.1296.9510.2410.56
243PCB 810.889.4815.1716.95106.4216.5516.1987.1311.2912.96104.542.162.0799.168.648.71
244PCB 1010.4111.6512.5419.14117.3414.1812.0895.122.943.09101.235.715.64101.0110.1210.02
245PCB 1050.4102.2314.6613.90126.3914.9819.7688.397.678.68105.838.197.7493.215.055.42
246PCB 1140.896.4920.6919.42103.4613.8713.4194.8811.0411.64104.475.355.1298.797.127.21
247PCB 1181.2 102.1911.5311.2894.038.108.6198.744.784.8498.208.768.92
248PCB 1231.2 113.4322.0519.4490.087.668.50102.248.398.2196.455.295.48
249PCB 1260.887.4218.2919.43111.0414.5713.1291.667.708.40107.909.859.1396.397.948.24
250PCB 1380.4118.8220.4518.79105.0311.5811.03102.6410.099.83105.836.526.1696.846.406.61
251PCB 1530.8105.6717.5120.11110.878.227.4196.927.417.65101.594.874.7997.133.453.55
252PCB 1560.889.9417.4919.45115.2523.3320.2490.967.998.78106.257.737.2898.319.189.34
253PCB 1570.882.2219.4317.63116.2420.0417.2488.007.668.70107.189.208.58101.2010.3310.21
254PCB 1670.887.2718.7421.47111.1116.5323.8895.419.509.96105.127.647.2797.8810.5910.82
255PCB 1691.2 99.0518.8917.1798.139.8410.03103.4710.129.7896.448.729.04
256PCB 1800.4106.0419.0020.25108.1415.0112.3794.399.8210.40109.049.098.3497.267.547.75
257PCB 1890.879.2218.6010.4597.1419.0219.5886.3910.8112.51108.007.226.6992.104.184.54
258Penconazole0.8119.4710.6618.9796.8018.5019.1181.7813.6516.6994.227.107.54103.418.498.21
259Pencycuron0.4110.8213.2611.9790.3611.6312.8786.1710.6812.3998.983.843.88101.166.826.74
260Pendimethalin2 102.8819.8619.3075.0616.2121.60104.565.385.1594.4011.9912.70
261Penicillin V8 105.2218.1017.20108.536.816.27
262Permethrin4 113.3417.5815.51115.6716.4614.2398.5412.8713.06
263Phenanthrene1.6 133.7410.565.4894.0013.6514.5299.6716.6816.7493.744.354.64
264Phenylbutazone16 110.3217.6821.84
265Phosalone0.4110.5017.3815.7398.288.368.5189.915.275.86101.982.802.75102.702.352.29
266Phosmet1.2 100.606.025.9892.4912.4213.43101.795.925.82104.635.425.18
267Pthalamide (Folpet deg)8 103.7911.7111.28100.456.356.32
268Pirimicarb0.4120.228.006.6595.324.744.9793.0911.1311.96102.454.634.52103.602.502.41
269Pirimicarb-desmethyl2 110.387.616.89127.7912.9210.11114.998.237.16123.054.573.71
270Pirimiphos ethyl0.882.7517.5021.1592.129.5010.3198.1112.1012.33120.3911.929.90101.286.047.51
271Pirimiphos methyl0.4111.7915.9814.2995.4516.0216.7888.6710.1411.44102.624.304.19101.906.746.61
272Prochloraz0.4104.3917.4316.7091.035.005.4989.2711.4612.84100.965.855.79103.415.285.11
273Procymidone8 92.0215.0916.40106.3516.6315.04
274Profenofos0.8115.1018.6317.9193.4017.4018.6388.4619.4321.9684.425.947.04108.507.246.67
275Propamocarb2 114.9419.1516.6693.172.452.6399.379.659.71103.217.967.71
276Propargite0.4113.517.836.9097.284.474.5990.046.016.6799.271.992.00100.595.365.33
277Propiconazole2 103.2116.1915.3898.4910.5310.69103.633.303.18
278Propoxur0.8124.7520.2315.0892.348.008.6693.2618.9020.27101.628.077.94111.033.683.31
279Propyzamide (pronamide)0.8104.0319.4219.7489.5816.1419.1893.0213.3914.3997.325.916.07102.927.647.42
280Proquinazid1.6 102.9915.8415.3892.933.724.00116.3113.6811.7695.048.789.24
281Prothioconazol1.6 118.9417.9915.1386.9410.7712.39101.867.036.90103.495.024.85
282Prothiophos2 127.3517.5215.0391.2211.4312.53110.7316.3614.7790.197.428.23
283Pymetrozine8 95.533.633.8099.155.845.89
284Pyraclostrobin0.4118.1014.3312.1388.905.976.7290.622.372.6297.963.113.17101.934.864.77
285Pyrazophos0.4116.3417.0214.6387.655.376.1395.1510.1110.63103.827.887.59104.453.193.05
286Pyrene2 122.2619.3315.1295.9715.4916.1499.997.057.05106.9713.2012.34
287Pyridaben0.4111.808.507.6096.9611.3411.7089.297.378.2597.163.543.64101.945.965.85
288Pyridaphenthion0.4125.3310.878.6788.8612.1813.7190.699.1710.11103.365.755.56104.972.292.18
289Pyrimethanil1.2 107.016.576.1483.426.567.8699.984.424.42106.143.933.70
290Pyriproxifen0.4108.806.846.2993.685.816.2084.684.335.1199.264.884.9297.2110.3610.66
291Quinalfos1.6 90.1415.9117.6581.5614.4817.7598.7815.6415.8399.056.286.34
292Quinoxyfen0.8106.7920.6520.64102.2914.6814.2792.0612.9814.10113.553.753.3088.938.369.40
293Rifampicin1.2 103.0018.5917.7689.3413.6515.2899.637.957.98111.8715.9514.26
294Rotenone0.8120.7016.4613.6489.1417.5320.8881.9214.3417.50101.3412.3612.20105.213.733.55
295Roxithromycin1.2 116.4519.3716.6388.8912.8914.5088.8516.6718.76102.533.022.95
296Sarafloxacin20 102.2816.9016.52
297Simazine0.8127.2622.7317.8689.6013.2514.7990.5313.3814.78101.607.917.79108.748.427.74
298Spinosad (two isomers)1.6111.7219.8117.7390.1414.7016.3189.329.2610.3799.295.465.50100.877.977.90
299Spiramycin (two isomers)12 105.212.312.2098.926.556.62
300Spirodiclofen0.8114.3010.248.9698.979.739.8386.323.994.6296.724.664.8296.102.652.76
301Spiromesifen0.4111.8716.9415.1496.8810.6210.9681.939.6411.7796.255.786.01102.026.816.68
302Spirotetramat0.8136.5414.9918.3091.5815.2917.6287.6516.8719.2599.1910.6010.69109.757.106.47
303Spiroxamine0.4115.955.124.4292.275.976.4793.014.624.97100.045.415.41101.942.102.06
304Strychnine2 121.8215.5916.2684.1920.3420.16100.685.595.55102.955.885.71
305Sulfacetamide16 94.809.9610.51
306Sulfachloropiridacine4 109.3718.2416.6898.927.847.93102.016.916.77
307Sulfadiacine8 91.594.524.9487.739.5410.87
308Sulfadimetoxine2 126.5415.1110.31109.8911.0810.08103.698.017.72103.973.743.60
309Sulfadoxine2 123.1711.688.48107.0513.0612.20100.757.537.47106.397.086.65
310Sulfameracine4 118.068.767.4295.453.063.21102.433.583.50
311Sulfametacine2 118.2612.288.28105.3312.8412.19102.147.006.85104.354.924.71
312Sulfametizole4 108.417.697.0997.154.814.95101.7512.2412.03
313Sulfametoxazole2 117.5319.3321.7699.366.596.63100.105.775.76104.0810.5010.09
314Sulfametoxipiridacine1.6 122.5610.027.2393.7615.0416.0495.824.124.30106.046.025.68
315Sulfamonomethoxine4 115.8219.1016.49109.039.008.25102.715.895.73
316Sulfapyridine4 123.125.814.7297.405.435.5797.955.035.14
317Sulfaquinoxaline2 137.1315.8611.57107.0916.4615.37103.038.498.24105.725.775.46
318Sulfatiazole4 114.0912.1710.6789.173.003.3696.759.669.98
319Sulfisoxazole4 123.1715.5512.62109.156.856.28102.569.839.58
320Tebuconazole2 124.3310.868.73102.259.829.60103.1810.279.95100.506.556.52
321Tebufenocide0.8113.4019.3017.0294.016.426.8388.386.076.8799.162.482.5099.925.265.26
322Tebufenpyrad0.8125.3118.0114.37106.175.545.2288.4711.6813.2096.734.955.12106.062.212.08
323Teflubenzuron1.6 108.5719.0617.5689.655.826.49100.5212.2812.22104.304.234.06
324Tefluthrin0.4124.3621.6416.23105.0019.0518.1488.4412.1513.74105.917.757.3289.591.301.45
325Telodrin (isobenzan)2 121.9212.8521.3188.0314.4917.82108.275.895.4499.0917.3617.52
326Terbufos0.8104.0914.2113.2688.6815.2116.3281.588.129.95110.159.528.6495.995.505.73
327Terbuthylazine0.8120.919.868.1593.7718.0619.2685.939.7811.38106.012.622.47104.194.524.34
328Tetrachlorvinphos2 126.8117.7813.00100.0519.1919.1888.069.9411.2998.2013.0413.28
329Tetraconazole0.8116.6614.5320.6090.4017.4319.2889.899.7810.88115.707.746.6988.105.706.47
330Tetradifon1.6 106.9212.9919.5091.9711.8712.91112.565.805.1594.922.682.82
331Tetramethrin2 120.3014.8912.38113.618.457.4499.3515.7815.88
332Thiabendazole1.2 96.7217.2116.2686.006.757.85109.004.574.1995.597.217.54
333Thiacloprid0.8121.347.445.6690.026.387.0988.4114.8716.82108.683.583.29110.315.935.38
334Thiamethoxam8 121.066.355.2592.875.215.61
335Thiophanate methyl2 124.158.096.03101.9512.2312.00106.086.235.87103.967.367.08
336Tolclofos methyl1.6 123.5915.0712.1984.625.686.71109.417.306.6796.185.786.01
337Tolfenamic acid1.6 105.3115.5420.30104.7616.0115.2896.523.583.7197.335.085.22
338Triadimefon1.2 94.1515.0916.3395.627.487.82101.846.276.16103.912.782.68
339Triadimenol0.8114.2111.559.26106.4013.8014.6589.3412.9314.47103.346.456.24106.445.745.39
340Triazophos (hostathion)0.4112.5015.6312.7691.776.146.6991.6811.4912.53104.863.623.45102.764.434.31
341Trifloxystrobin0.4112.8713.1211.6292.565.896.3693.354.785.12100.812.862.84102.514.764.64
342Triflumizole0.4110.089.268.4194.017.017.4693.267.628.1799.912.692.69101.623.673.61
343Triflumuron1.2 118.6619.2416.2186.937.788.9596.653.904.04106.186.376.00
344Trifluralin1.2 93.2917.7819.0692.406.376.89105.899.839.2893.544.174.46
345Trimethoprim2 116.0216.5412.16109.2115.0513.7894.2012.5113.2897.928.708.88
346Triticonazole1.2 99.198.608.6789.7112.7114.17100.848.678.60104.044.364.19
347Tylmicosin4 107.1416.7015.5993.586.977.45101.1811.1911.06
348Tylosin8 106.354.464.19104.602.792.67
349Vinclozolin1.6 116.5223.4617.3088.9412.8214.41105.6012.4211.7692.864.925.30
350Warfarin0.8100.4717.5119.8995.539.129.5585.6111.1914.7593.096.286.75103.654.314.16
351Zoxamide0.8121.9619.5218.4788.5011.1313.8890.5719.3320.34106.935.184.84105.406.446.11

Appendix C

Table A3. Matrix Effect, expressed as percentage, calculated for all of the analytes. The range form −20% to 20% represent the tolerance range in which it is considered that no significant matrix effect exists.
Table A3. Matrix Effect, expressed as percentage, calculated for all of the analytes. The range form −20% to 20% represent the tolerance range in which it is considered that no significant matrix effect exists.
No.CompoundMatriz effectNo.CompoundMatriz effectCompoundMatriz Effect
12-Phenylphenol−103.4118Eprinomectin−6.3235Oxolinic acid0.5
24,4′-Dichlorobenzophenone (metabolite of dicofol)96.6119Eritromicin45.4236Oxydemeton methyl3.3
3Abamectine−70.6120Esfenvalerate23.4237Oxyfluorfen42.4
4Acenaphthene14.3121Ethion (diethion)−13.7238Paclobutrazol3.0
5Acenaphtylene17.0122Ethirimol13.9239Parathion methyl12.8
6Acephate−90.4123Ethofumesate30.5240PCB 2832.5
7Acetamiprid7.0124Ethoprophos−20.5241PCB 5232.7
8Acrinathrin16.2125Etofenprox43.0242PCB 7752.5
9Albendazole17.7126Etoxazole−29.6243PCB 8143.7
10Aldicarb5.8127Famoxadone27.9244PCB 1018.2
11Aldicarb-sulfone−4.5128Fenamidone12.7245PCB 10554.6
12Aldicarb-sulfoxide−2.9129Fenamiphos14.0246PCB 11446.6
13Aldrin43.7130Fenamiphos sulfone10.4247PCB 11845.0
14Anthracene23.9131Fenamiphos sulfoxide0.0248PCB 12345.7
15Atrazine7.8132Fenarimol55.3249PCB 12652.1
16Azinphos-methyl14.3133Fenazaquin−108.8250PCB 13854.9
17Azoxystrobin−6.9134Fenbendazole−7.9251PCB 15348.2
18BDE-2847.0135Fenbuconazole67.7252PCB 15659.3
19BDE-4747.8136Fenhexamid5.9253PCB 15751.6
20BDE-8543.7137Fenitrothion54.6254PCB 16760.1
21BDE-9957.3138Fenoxycarb16.4255PCB 16960.6
22BDE-10051.3139Fenpropathrin−2.2256PCB 18052.5
23BDE-15335.9140Fenpropidin22.3257PCB 18954.8
24BDE-15457.8141Fenpropimorph1.7258Penconazole50.4
25BDE-183−14.1142Fenpyroximate19.8259Pencycuron−37.4
26Benalaxyl−111.5143Fenthion−33.9260Pendimethalin29.8
27Bendiocarb−5.4144Fenthion oxon27.1261Penicillin V−8.1
28Bendiocarb metabolite (2,2-dimethylbenzo-1,3-dioxol-4-ol)39.7145Fenthion oxon sulfone5.3262Permethrin71.5
29Benfuracarb24.0146Fenthion oxon sulfoxide3.7263Phenanthrene29.6
30Benzo[a]anthracene58.5147Fenthion sulfone6.9264Phenylbutazone−4.9
31Benzo[a]pyrene45.0148Fenthion sulfoxide11.9265Phosalone−4.0
32Benzo[b]fluoranthene59.8149Fenvalerate−39.6266Phosmet5.8
33Benzo[ghi]perylene24.4150Fipronil21.0267Pthalamide (Folpet deg)59.3
34Benzo[k]fluoranthene38.1151Fipronil sulfide676.5268Pirimicarb1.7
35Bifenthrin80.4152Flocoumafen−34.5269Pirimicarb-desmethyl57.7
36Bitertanol−0.7153Fluazinam−1.5270Pirimiphos ethyl60.5
37Boscalid (formerly nicobifen)73.5154Flubendiamide62.7271Pirimiphos methyl−14.7
38Brodifacoum−31.7155Flucythrinate (two isomers)4.0272Prochloraz−37.2
39Bromadiolone−2.1156Fludioxonil61.2273Procymidone52.9
40Bromopropylate94.0157Flufenoxuron1.1274Profenofos−15.0
41Bromuconazole (two isomers)39.7158Flumequine−0.8275Propamocarb16.2
42Bupirimate57.0159Flunixin−9.4276Propargite−29.3
43Buprofezin−0.4160Fluopyram45.4277Propiconazole−85.8
44Cadusafos (ebufos)−54.8161Fluoranthene36.0278Propoxur−7.1
45Carbaryl15.8162Fluorene17.2279Propyzamide (pronamide)−2.0
46Carbendazim (azole)16.8163Fluquinconazole55.3280Proquinazid72.7
47Carbofuran−9.0164Flusilazole3.8281Prothioconazol51.5
48Carbofuran-3-hydroxy5.5165Flutolanil−10.2282Prothiophos49.5
49Carbosulfan−107.2166Flutriafol54.5283Pymetrozine16.2
50Cefuroxima axetil (two isomers)24.0167Fluvalinate tau−31.7284Pyraclostrobin−18.0
51Chloramphenicol24.4168Fonofos28.9285Pyrazophos20.6
52Chlorantraniliprole4.5169Formetanate−38.7286Pyrene45.1
53Chlorfenvinphos−31.3170Fosthiazate2.9287Pyridaben−83.6
54Chlorobenzilate95.2171Heptachlor−110.9288Pyridaphenthion14.3
55Chlorophacinone38.1172Hexachlorobencene16.9289Pyrimethanil30.6
56Chlorpropham24.2173Hexachlorocyclohexane (alpha)−58.1290Pyriproxifen−24.8
57Chlorpyrifos38.0174Hexachlorocyclohexane (beta)−97.4291Quinalfos3.7
58Chlorpyrifos methyl9.6175Hexachlorocyclohexane (delta)−89.1292Quinoxyfen−68.5
59Chlorthal dimethyl36.6176Hexaclorocyclohexane (gamma. lindane)−109.8293Rifampicin−68.9
60Chrysene38.1177Hexaconazole (two isomers)−4.6294Rotenone22.0
61Clindamycin−7.5178Hexaflumuron−1.3295Roxithromycin0.0
62Clofentezine13.2179Hexythiazox−27.6296Sarafloxacin114.8
63Clothianidin17.7180Imazalil (enilconazole)11.5297Simazine−19.7
64Cloxacillin4.9181Imidacloprid4.1298Spinosad (two isomers)−84.2
65Coumachlor46.2182Indeno [1,2,3-cd] pyrene−132.0299Spiramycin (two isomers)16.8
66Coumaphos−105.9183Indoxacarb2.6300Spirodiclofen−12.7
67Coumatetralyl−25.6184Iprovalicarb−4.9301Spiromesifen−23.6
68Cyazofamid12.7185Isofenphos methyl42.0302Spirotetramat−34.1
69Cyflufenamid−3.0186Isoprothiolane−13.5303Spiroxamine9.4
70Cyfluthrin (sum of four isomers)−6.1187Ivermectin B1a−82.6304Strychnine11.9
71Cyhalothrin (lambda isomer)−22.4188Josamycin−0.4305Sulfacetamide−27.9
72Cymoxanil13.6189Ketoprofen10.0306Sulfachloropiridacine61.1
73Cypermethrin (sum of four isomers)20.9190Kresoxim methyl36.3307Sulfadiacine−15.0
74Cyproconazole (two isomers)8.2191Levamisole10.0308Sulfadimetoxine18.2
75Cyprodinil−5.7192Lincomycin135.3309Sulfadoxine2.2
76Cyromazine−106.0193Linuron0.0310Sulfameracine83.7
77Danofloxacin172.1194Lufenuron7.3311Sulfametacine166.8
78Dazomet33.1195Mandipropamid20.6312Sulfametizole170.5
79Deltamethrin−33.7196Mebendazole11.5313Sulfametoxazole26.0
80Demeton-S-methyl−27.1197Mefenamic acid33.5314Sulfametoxipiridacine107.7
81Demeton-S-methyl-sulfone (Dioxydemeton)7.5198Mefenoxam (metalaxyl-M)−5.9315Sulfamonomethoxine1.7
82Dexamethasone5.4199Meloxicam34.8316Sulfapyridine24.6
83Diazinon22.3200Mepanipyrim64.2317Sulfaquinoxaline2.5
84Dibenzo[a.h]anthracene35.2201Mepiquat−57.2318Sulfatiazole32.5
85Dichlorodiphenyldichloroethane (p,p′ DDD)14.9202Metaflumizone5.4319Sulfisoxazole11.6
86Dichlorodiphenyldichloroethylene (p,p′ DDE)44.5203Metalaxyl−47.0320Tebuconazole−72.1
87Dichlorodiphenyltrichloroethane (p,p′ DDT)−124.9204Metaldehyde−25.7321Tebufenocide−7.8
88Diclofenac8.6205Metconazole−26.1322Tebufenpyrad7.9
89Dicloran−0.4206Methamidophos (two isomers)−16.6323Teflubenzuron−31.5
90Diclorvos−42.8207Methidathion7.1324Tefluthrin33.9
91Dicloxacillin−4.4208Methiocarb6.2325Telodrin (isobenzan)−22.0
92Dieldrin19.7209Methiocarb-sufone3.0326Terbufos24.0
93Diethathyl ethyl−15.6210Methiocarb-sulfoxide3.0327Terbuthylazine29.2
94Diethofencarb7.5211Methomyl1.8328Tetrachlorvinphos1.1
95Difenacoum7.8212Methoxyfenozide−7.0329Tetraconazole48.4
96Difenoconazole−21.3213Metoxychlor−124.6330Tetradifon41.7
97Difethialone16.8214Metrafenone6.1331Tetramethrin154.7
98Difloxacin99.9215Metronidazole−13.3332Thiabendazole67.7
99Diflubenzuron38.5216Mevinphos (phosdrin)−3.3333Thiacloprid12.3
100Diflufenican8.1217Mirex−82.6334Thiamethoxam19.7
101Dimethenamid-P (and its R-isomer)8.7218Monocrotophos−1.2335Thiophanate methyl−4.2
102Dimethoate4.8219Moxidectin20.7336Tolclofos methyl21.0
103Dimethomorph (two isomers)24.2220Myclobutanil24.7337Tolfenamic acid136.0
104Dimethylphenylsulfamide (DMSA, metabolite of dichlofluanid)4.9221N-(2,4-dimethylphenyl)-N′-methylformamidine (DMPF, metabolite of amitraz)9.6338Triadimefon20.6
105Diniconazole-M−11.4222N,N-Dimethyl-N′-p-tolylsulphamide (DMST, metabolite of tolyfluanid)−8.2339Triadimenol27.9
106Dinocap−11.9223Nafcillin−8.2340Triazophos (hostathion)−6.3
107Diphacinone14.1224Naphtalene12.9341Trifloxystrobin−55.8
108Diphenylamine−102.4225Naproxen16.5342Triflumizole−14.3
109Dodine−92.0226Nitenpyram−4.5343Triflumuron3.6
110Doramectina−16.2227Novobiocin2.9344Trifluralin−1.7
111Endosulfan alfa−2.5228Nuarimol74.1345Trimethoprim25.2
112Endosulfan beta−52.9229Ofurace−27.2346Triticonazole13.7
113Endosulfan sulfate−85.8230Omethoate−0.4347Tylmicosin140.3
114Endrin−59.9231Oxadixyl6.5348Tylosin−1.7
115Enrofloxacin141.8232Oxamyl2.6349Vinclozolin33.9
116EPN32.6233Oxamyl-oxime30.1350Warfarin0.0
117Epoxiconazole10.0234Oxfendazole7.0351Zoxamide−83.0

References

  1. Bártíková, H.; Podlipná, R.; Skálová, L. Veterinary drugs in the environment and their toxicity to plants. Chemosphere 2016, 144, 2290–2301. [Google Scholar] [CrossRef] [PubMed]
  2. Izadi, P.; Salem, R.; Papry, S.A.; Magdouli, S.; Pulicharla, R.; Brar, S.K. Non-steroidal anti-inflammatory drugs in the environment: Where were we and how far we have come? Environ. Pollut. 2020, 267, 115370. [Google Scholar] [CrossRef] [PubMed]
  3. Bacanlı, M.; Başaran, N. Importance of antibiotic residues in animal food. Food Chem. Toxicol. 2019, 125, 462–466. [Google Scholar] [CrossRef] [PubMed]
  4. Chicoine, A.; Erdely, H.; Fattori, V.; Finnah, A.; Fletcher, S.; Lipp, M.; Sanders, P.; Scheid, S. Assessment of veterinary drug residues in food: Considerations when dealing with sub-optimal data. Regul. Toxicol. Pharmacol. 2020, 118, 104806. [Google Scholar] [CrossRef] [PubMed]
  5. Masiá, A.; Suarez-Varela, M.M.; Llopis-Gonzalez, A.; Picó, Y. Determination of pesticides and veterinary drug residues in food by liquid chromatography-mass spectrometry: A review. Anal. Chim. Acta 2016, 936, 40–61. [Google Scholar] [CrossRef] [PubMed]
  6. Chen, J.; Ying, G.-G.; Deng, W.-J. Antibiotic Residues in Food: Extraction, Analysis, and Human Health Concerns. J. Agric. Food Chem. 2019, 67, 7569–7586. [Google Scholar] [CrossRef]
  7. Council of the European Union EUR-Lex—31996L0023—EN. Off. J. L 125, 23/05/1996 P. 0010—0032. 1996.
  8. Fox, G.A. Wildlife as sentinels of human health effects in the Great Lakes-St. Lawrence basin. Environ. Health Perspect. 2001, 109, 853–861. [Google Scholar]
  9. Grove, R.A.; Henny, C.J.; Kaiser, J.L. Osprey: Worldwide Sentinel Species for Assessing and Monitoring Environmental Contamination in Rivers, Lakes, Reservoirs, and Estuaries. J. Toxicol. Environ. Health Part B 2009, 12, 25–44. [Google Scholar] [CrossRef]
  10. Calafat, A.M.; Ye, X.; Silva, M.J.; Kuklenyik, Z.; Needham, L.L. Human exposure assessment to environmental chemicals using biomonitoring. Int. J. Androl. 2006, 29, 166–171. [Google Scholar] [CrossRef]
  11. Noyes, P.D.; McElwee, M.; Miller, H.D.; Clark, B.W.; Van Tiem, L.A.; Walcott, K.C.; Erwin, K.N.; Levin, E.D. The toxicology of climate change: Environmental contaminants in a warming world. Environ. Int. 2009, 35, 971–986. [Google Scholar] [CrossRef]
  12. Schwartz, A.L.W.; Shilling, F.M.; Perkins, S.E. The value of monitoring wildlife roadkill. Eur. J. Wildl. Res. 2020, 66, 1–12. [Google Scholar] [CrossRef] [Green Version]
  13. Saulovic, D.; Biocanin, R.; Rodriguez, B. Bioindicators in Human Environment; University of Belgrade: Belgrade, Serbia, 2015. [Google Scholar]
  14. Megharaj, M.; Ramakrishnan, B.; Venkateswarlu, K.; Sethunathan, N.; Naidu, R. Bioremediation approaches for organic pollutants: A critical perspective. Environ. Int. 2011, 37, 1362–1375. [Google Scholar] [CrossRef]
  15. Wang, W.-X. Bioaccumulation and Biomonitoring. In Marine Ecotoxicology; Academic Press: Cambridge, MA, USA, 2016; pp. 99–119. [Google Scholar] [CrossRef]
  16. Rial-Berriel, C.; Dacal, A.C.A.; Zumbado, M.; Luzardo, O.P. Micro QuEChERS-based method for the simultaneous biomonitoring in whole blood of 360 toxicologically relevant pollutants for wildlife. Sci. Total Environ. 2020, 736, 139444. [Google Scholar] [CrossRef] [PubMed]
  17. Brancato, A.; Brocca, D.; De Lentdecker, C.; Erdos, Z.; Ferreira, L.; Greco, L.; Jarrah, S.; Kardassi, D.; Leuschner, R.; Lythgo, C.; et al. Review of the existing maximum residue levels for bromadiolone according to Article 12 of Regulation (EC) No 396/2005. EFSA J. 2017, 15. [Google Scholar] [CrossRef] [Green Version]
  18. Amutova, F.; Delannoy, M.; Baubekova, A.; Konuspayeva, G.; Jurjanz, S. Transfer of persistent organic pollutants in food of animal origin—Meta-analysis of published data. Chemosphere 2020, 262, 128351. [Google Scholar] [CrossRef] [PubMed]
  19. Thompson, L.A.; Darwish, W.S. Environmental Chemical Contaminants in Food: Review of a Global Problem. J. Toxicol. 2019, 2019, 1–14. [Google Scholar] [CrossRef] [Green Version]
  20. Rather, I.A.; Koh, W.Y.; Paek, W.K.; Lim, J. The Sources of Chemical Contaminants in Food and Their Health Implications. Front. Pharmacol. 2017, 8, 830. [Google Scholar] [CrossRef] [Green Version]
  21. Carvalho, F.P. Pesticides, environment, and food safety. Food Energy Secur. 2017, 6, 48–60. [Google Scholar] [CrossRef]
  22. Kaczyński, P.; Łozowicka, B.; Perkowski, M.; Szabuńko, J. Multiclass pesticide residue analysis in fish muscle and liver on one-step extraction-cleanup strategy coupled with liquid chromatography tandem mass spectrometry. Ecotoxicol. Environ. Saf. 2017, 138, 179–189. [Google Scholar] [CrossRef]
  23. Kittlaus, S.; Schimanke, J.; Kempe, G.; Speer, K. Development and validation of an efficient automated method for the analysis of 300 pesticides in foods using two-dimensional liquid chromatography–tandem mass spectrometry. J. Chromatogr. A 2013, 1283, 98–109. [Google Scholar] [CrossRef]
  24. Rizzetti, T.M.; Souza, M.; Prestes, O.D.; Adaime, M.; Zanella, R. Optimization of sample preparation by central composite design for multi-class determination of veterinary drugs in bovine muscle, kidney and liver by ultra-high-performance liquid chromatographic-tandem mass spectrometry. Food Chem. 2018, 246, 404–413. [Google Scholar] [CrossRef]
  25. Kaufmann, A.; Butcher, P.; Maden, K.; Widmer, M. Quantitative multiresidue method for about 100 veterinary drugs in different meat matrices by sub 2-μm particulate high-performance liquid chromatography coupled to time of flight mass spectrometry. J. Chromatogr. A 2008, 1194, 66–79. [Google Scholar] [CrossRef] [PubMed]
  26. Kinsella, B.; Lehotay, S.J.; Mastovska, K.; Lightfield, A.R.; Furey, A.; Danaher, M. New method for the analysis of flukicide and other anthelmintic residues in bovine milk and liver using liquid chromatography–tandem mass spectrometry. Anal. Chim. Acta 2009, 637, 196–207. [Google Scholar] [CrossRef]
  27. Filigenzi, M.S.; Ehrke, N.; Aston, L.S.; Poppenga, R.H. Evaluation of a rapid screening method for chemical contaminants of concern in four food-related matrices using QuEChERS extraction, UHPLC and high resolution mass spectrometry. Food Addit. Contam. Part A 2011, 28, 1324–1339. [Google Scholar] [CrossRef]
  28. Rial-Berriel, C.; Dacal, A.C.A.; González, F.; Pastor-Tiburón, N.; Zumbado, M.; Luzardo, O.P. Supporting dataset on the validation and verification of the analytical method for the biomonitoring of 360 toxicologically relevant pollutants in whole blood. Data Brief. 2020, 31, 105878. [Google Scholar] [CrossRef]
  29. Anastassiades, M.; Lehotay, S.J.; Štajnbaher, D.; Schenck, F.J. Fast and Easy Multiresidue Method Employing Acetonitrile Extraction/Partitioning and “Dispersive Solid-Phase Extraction” for the Determination of Pesticide Residues in Produce. J. AOAC Int. 2003, 86, 412–431. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Acosta-Dacal, A.; Rial-Berriel, C.; Díaz-Díaz, R.; Bernal-Suárez, M.D.M.; Luzardo, O.P. Optimization and validation of a QuEChERS-based method for the simultaneous environmental monitoring of 218 pesticide residues in clay loam soil. Sci. Total Environ. 2020, 753, 142015. [Google Scholar] [CrossRef]
  31. Perestrelo, R.; Silva, P.; Porto-Figueira, P.; Pereira, J.A.M.; Silva, C.; Medina, S.; Câmara, J.S. QuEChERS—Fundamentals, relevant improvements, applications and future trends. Anal. Chim. Acta 2019, 1070, 1–28. [Google Scholar] [CrossRef] [PubMed]
  32. EC Commission Implementing Regulation (EU) 2021/808 of 22 March 2021 on the performance of analytical methods for residues of pharmacologically active substances used in food-producing animals and on the interpretation of results as well as on the methods to be used for sampling and repealing Decisions 2002/657/EC and 98/179/EC. Off. J. Eur. Union 2021, 180–184.
  33. Scientific Working Group for Forensic Toxicology Scientific Working Group for Forensic Toxicology (SWGTOX) Standard Practices for Method Validation in Forensic Toxicology. J. Anal. Toxicol. 2013, 37, 452–474. [CrossRef] [PubMed]
  34. SANTE/12682 Guidance document on analytical quality control and validation procedures for pesticide residues analysis in food and feed. Eur. Comm. Heal. Consum. Prot. Dir. 2019, 2–44.
  35. European Commission Analytical Quality Control and Method Validation for Pesticide Residues Analysis in Food and Feed (SANTE/12682/2019). Sante/12682/2019 2019.
  36. BOC Orden 1489, de 28 de Marzo de 2014, Por el Que se Aprueba la Estrategia Para la Erradicación del Uso Ilegal de Veneno en el Medio no Urbano de Canarias 2014. 9252–9324.
  37. Acosta-Dacal, A.; Rial-Berriel, C.; Díaz-Díaz, R.; Suárez, M.D.M.B.; Zumbado, M.; Henríquez-Hernández, L.A.; Luzardo, O.P. Supporting dataset on the optimization and validation of a QuEChERS-based method for the determination of 218 pesticide residues in clay loam soil. Data Brief. 2020, 33, 106393. [Google Scholar] [CrossRef]
  38. Maštovská, K.; Lehotay, S.J. Evaluation of common organic solvents for gas chromatographic analysis and stability of multiclass pesticide residues. J. Chromatogr. A 2004, 1040, 259–272. [Google Scholar] [CrossRef]
  39. Rodríguez-Hernández, A.; Camacho, M.; Henríquez-Hernández, L.A.; Boada, L.D.; Ruiz-Suárez, N.; Valerón, P.F.; González, M.A.; Zaccaroni, A.; Zumbado, M.; Luzardo, O.P. Assessment of human health hazards associated with the dietary exposure to organic and inorganic contaminants through the consumption of fishery products in Spain. Sci. Total Environ. 2016, 557-558, 808–818. [Google Scholar] [CrossRef] [PubMed]
  40. Rodríguez-Hernández, A.; Boada, L.D.; Mendoza, Z.; Ruiz-Suárez, N.; Valerón, P.F.; Camacho, M.; Zumbado, M.; Almeida-González, M.; Henriquez-Hernandez, L.A.; Luzardo, O.P. Consumption of organic meat does not diminish the carcinogenic potential associated with the intake of persistent organic pollutants (POPs). Environ. Sci. Pollut. Res. 2015, 24, 4261–4273. [Google Scholar] [CrossRef] [PubMed]
  41. Rodríguez-Hernández, A.; Camacho, M.; Henríquez-Hernández, L.A.; Boada, L.D.; Valerón, P.F.; Zaccaroni, A.; Zumbado, M.; Almeida-González, M.; Rial-Berriel, C.; Luzardo, O.P. Comparative study of the intake of toxic persistent and semi persistent pollutants through the consumption of fish and seafood from two modes of production (wild-caught and farmed). Sci. Total Environ. 2017, 575, 919–931. [Google Scholar] [CrossRef] [PubMed]
  42. Rodríguez-Hernández, A.; Boada, L.D.; Almeida-González, M.; Mendoza, Z.; Ruiz-Suárez, N.; Valeron, P.F.; Camacho, M.; Zumbado, M.; Henríquez-Hernández, L.A.; Luzardo, O.P. An estimation of the carcinogenic risk associated with the intake of multiple relevant carcinogens found in meat and charcuterie products. Sci. Total Environ. 2015, 514, 33–41. [Google Scholar] [CrossRef] [PubMed]
  43. Henríquez-Hernández, L.A.; Montero, D.; Camacho, M.; Ginés, R.; Boada, L.D.; Bordón, B.R.; Valerón, P.F.; Almeida-González, M.; Zumbado, M.; Haroun, R.; et al. Comparative analysis of selected semi-persistent and emerging pollutants in wild-caught fish and aquaculture associated fish using Bogue (Boops boops) as sentinel species. Sci. Total Environ. 2017, 581-582, 199–208. [Google Scholar] [CrossRef]
  44. López-Sobaler, A.M.; Aparicio, A.; Rubio, J.; Marcos, V.; Sanchidrián, R.; Santos, S.; Pérez-Farinós, N.; Dal-Re, M.; Villar-Villalba, C.; Yusta-Boyo, M.J.; et al. Adequacy of usual macronutrient intake and macronutrient distribution in children and adolescents in Spain: A National Dietary Survey on the Child and Adolescent Population, ENALIA 2013–2014. Eur. J. Nutr. 2018, 58, 705–719. [Google Scholar] [CrossRef] [Green Version]
  45. Ruiz-Suárez, N.; Henriquez-Hernandez, L.A.; Valerón, P.F.; Boada, L.D.; Zumbado, M.; Camacho, M.; González, M.A.; Luzardo, O.P. Assessment of anticoagulant rodenticide exposure in six raptor species from the Canary Islands (Spain). Sci. Total Environ. 2014, 485-486, 371–376. [Google Scholar] [CrossRef]
  46. García-Álvarez, N.; Boada, L.D.; Fernández, A.; Zumbado, M.; Arbelo, M.; Sierra, E.; Xuriach, A.; Almunia, J.; Camacho, M.; Luzardo, O.P. Assessment of the levels of polycyclic aromatic hydrocarbons and organochlorine contaminants in bottlenose dolphins (Tursiops truncatus) from the Eastern Atlantic Ocean. Mar. Environ. Res. 2014, 100, 48–56. [Google Scholar] [CrossRef] [PubMed]
  47. Camacho, M.; Boada, L.D.; Orós, J.; Lopez, P.; Zumbado, M.; Almeida-González, M.; Luzardo, O.P. Comparative Study of Organohalogen Contamination Between Two Populations of Eastern Atlantic Loggerhead Sea Turtles (Caretta caretta). Bull. Environ. Contam. Toxicol. 2013, 91, 678–683. [Google Scholar] [CrossRef] [PubMed]
  48. Henríquez-Hernández, L.A.; Luzardo, O.P.; Arellano, J.L.P.; Carranza, C.; Sánchez, N.J.; Almeida-González, M.; Ruiz-Suárez, N.; Valerón, P.F.; Camacho, M.; Zumbado, M.; et al. Different Pattern of Contamination by Legacy POPs in Two Populations from the Same Geographical Area but with Completely Different Lifestyles: Canary Islands (Spain) vs. Morocco. Sci. Total Environ. 2016, 541, 51–57. [Google Scholar] [CrossRef] [PubMed]
  49. Rivero, J.; Henríquez-Hernández, L.A.; Luzardo, O.P.; Pestano, J.; Zumbado, M.; Boada, L.D.; Valerón, P.F. Differential Gene Expression Pattern in Human Mammary Epithelial Cells Induced by Realistic Organochlorine Mixtures Described in Healthy Women and in Women Diagnosed with Breast Cancer. Toxicol. Lett. 2016, 246, 42–48. [Google Scholar] [CrossRef]
  50. Henríquez-Hernández, L.A.; Luzardo, O.P.; Zumbado, M.; Serra-Majem, L.; Valerón, P.F.; Camacho, M.; Álvarez-Pérez, J.; Salas-Salvadó, J.; Boada, L.D. Determinants of Increasing Serum POPs in a Population at High Risk for Cardiovascular Disease. Results from the PREDIMED-CANARIAS Study. Environ. Res. 2017, 156, 477–484. [Google Scholar] [CrossRef]
  51. Luzardo, O.P.; Boada, L.D.; Carranza, C.; Ruiz-Sua´rez, N.; Henri´quez-Herna´ndez, L.A.; Valero´n, P.F.; Zumbado, M.; Camacho, M.; Arellano, J.L.P. Socioeconomic Development as a Determinant of the Levels of Organochlorine Pesticides and PCBs in the Inhabitants of Western and Central African Countries. Sci. Total Environ. 2014, 497–498, 97–105. [Google Scholar] [CrossRef]
  52. Plaza, P.I.; Martínez-Lopez, E.; Lambertucci, S.A. The perfect threat: Pesticides and vultures. Sci. Total Environ. 2019, 687, 1207–1218. [Google Scholar] [CrossRef]
  53. Sánchez-Barbudo, I.S.; Camarero, P.R.; Mateo, R. Primary and secondary poisoning by anticoagulant rodenticides of non-target animals in Spain. Sci. Total Environ. 2012, 420, 280–288. [Google Scholar] [CrossRef]
  54. Seljetun, K.O.; Sandvik, M.; Vindenes, V.; Eliassen, E.; Øiestad, E.L.; Madslien, K.; Moe, L. Comparison of anticoagulant rodenticide concentrations in liver and feces from apparently healthy red foxes. J. Vet. Diagn. Investig. 2020, 32, 560–564. [Google Scholar] [CrossRef]
  55. Rial-Berriel, C.; Acosta-Dacal, A.; Pérez, M.C.; Suárez-Pérez, A.; Melián, A.M.; Zumbado, M.; Hernández, L.A.H.; Ruiz-Suárez, N.; Hernández, A.R.; Boada, L.D.; et al. Dataset on the concentrations of anticoagulant rodenticides in raptors from the Canary Islands with geographic information. Data Brief. 2021, 34, 106744. [Google Scholar] [CrossRef]
  56. Rial-Berriel, C.; Acosta-Dacal, A.; Pérez, M.C.; Suárez-Pérez, A.; Melián, A.M.; Zumbado, M.; Hernández, L.A.H.; Ruiz-Suárez, N.; Hernández, A.R.; Boada, L.D.; et al. Intensive livestock farming as a major determinant of the exposure to anticoagulant rodenticides in raptors of the Canary Islands (Spain). Sci. Total Environ. 2020, 768, 144386. [Google Scholar] [CrossRef] [PubMed]
  57. Alomar, H.; Chabert, A.; Coeurdassier, M.; Vey, D.; Berny, P. Accumulation of anticoagulant rodenticides (chlorophacinone, bromadiolone and brodifacoum) in a non-target invertebrate, the slug, Deroceras reticulatum. Sci. Total Environ. 2018, 610-611, 576–582. [Google Scholar] [CrossRef] [PubMed]
  58. Elliott, J.E.; Hindmarch, S.; Albert, C.A.; Emery, J.; Mineau, P.; Maisonneuve, F. Exposure pathways of anticoagulant rodenticides to nontarget wildlife. Environ. Monit. Assess. 2013, 186, 895–906. [Google Scholar] [CrossRef] [PubMed]
  59. EC COMMISSION DECISION of 13 June 2007 concerning the non-inclusion of carbofuran in Annex I to Council Directive 91/414/EEC and the withdrawal of authorisations for plant protection products containing that substance (notified under document number C (2007). Off. J. Eur. Union 2007, 156, 30–31.
  60. Ogada, D.L. The power of poison: Pesticide poisoning of Africa’s wildlife. Ann. N. Y. Acad. Sci. 2014, 1322, 1–20. [Google Scholar] [CrossRef]
  61. Guzmán, M.M.; Marla-Mojica, P.; Romero, D.; Martínez-Lopez, E.; García-Fernández, A.J. Intentional poisoning of animals in southeastern Spain: A review of the veterinary toxicology service from Murcia, Spain. Vet. Hum. Toxicol. 2003, 45. [Google Scholar]
  62. Kwon, Y.-K.; Wee, S.-H.; Kim, J.-H. Pesticide Poisoning Events in Wild Birds in Korea from 1998 to 2002. J. Wildl. Dis. 2004, 40, 737–740. [Google Scholar] [CrossRef] [Green Version]
  63. Hernandez, M.; Margalida, A. Pesticide abuse in Europe: Effects on the Cinereous vulture (Aegypius monachus) population in Spain. Ecotoxicology 2008, 17, 264–272. [Google Scholar] [CrossRef]
  64. Ruiz-Suárez, N.; Boada, L.D.; Henriquez-Hernandez, L.A.; González-Moreo, F.; Suárez-Pérez, A.; Camacho, M.; Zumbado, M.; González, M.A.; Travieso-Aja, M.D.M.; Luzardo, O.P. Continued implication of the banned pesticides carbofuran and aldicarb in the poisoning of domestic and wild animals of the Canary Islands (Spain). Sci. Total Environ. 2015, 505, 1093–1099. [Google Scholar] [CrossRef]
  65. Panderi, I.; Bernauer, U. Opinion of the Scientific Committee on Consumer Safety (SCCS)—Revision of the opinion on o-Phenylphenol, Sodium o-phenylphenate and Potassium o-phenylphenate (OPP), in cosmetic products. Regul. Toxicol. Pharmacol. 2016, 79, 105. [Google Scholar] [CrossRef]
  66. Peng, X.; Zheng, K.; Liu, J.; Fan, Y.; Tang, C.; Xiong, S. Body size-dependent bioaccumulation, tissue distribution, and trophic and maternal transfer of phenolic endocrine-disrupting contaminants in a freshwater ecosystem. Environ. Toxicol. Chem. 2018, 37, 1811–1823. [Google Scholar] [CrossRef]
  67. Jaspers, V.; Covaci, A.; Voorspoels, S.; Dauwe, T.; Eens, M.; Schepens, P. Brominated flame retardants and organochlorine pollutants in aquatic and terrestrial predatory birds of Belgium: Levels, patterns, tissue distribution and condition factors. Environ. Pollut. 2006, 139, 340–352. [Google Scholar] [CrossRef]
  68. Corcellas, C.; Andreu, A.; Máñez, M.; Sergio, F.; Hiraldo, F.; Eljarrat, E.; Barceló, D. Pyrethroid insecticides in wild bird eggs from a World Heritage Listed Park: A case study in Doñana National Park (Spain). Environ. Pollut. 2017, 228, 321–330. [Google Scholar] [CrossRef] [PubMed]
  69. Abbasi, N.A.; Eulaers, I.; Jaspers, V.L.; Chaudhry, M.J.I.; Frantz, A.; Ambus, P.; Covaci, A.; Malik, R.N. Use of feathers to assess polychlorinated biphenyl and organochlorine pesticide exposure in top predatory bird species of Pakistan. Sci. Total Environ. 2016, 569-570, 1408–1417. [Google Scholar] [CrossRef]
  70. Nakayama, S.M.; Morita, A.; Ikenaka, Y.; Mizukawa, H.; Ishizuka, M. A review: Poisoning by anticoagulant rodenticides in non-target animals globally. J. Vet. Med. Sci. 2019, 81, 298–313. [Google Scholar] [CrossRef] [Green Version]
  71. Sullivan, J.P.; Wisk, J.D. Using the terrestrial residue exposure (T-REX) model to assess threatened and endangered bird exposure to and risk from pesticides. Integr. Environ. Assess. Manag. 2013, 9, 480–495. [Google Scholar] [CrossRef] [PubMed]
  72. Luzardo, O.P.; Ruiz-Suárez, N.; Henriquez-Hernandez, L.A.; Valerón, P.F.; Camacho, M.; Zumbado, M.; Boada, L.D. Assessment of the exposure to organochlorine pesticides, PCBs and PAHs in six species of predatory birds of the Canary Islands, Spain. Sci. Total Environ. 2014, 472, 146–153. [Google Scholar] [CrossRef] [PubMed]
Figure 1. MRM chromatograms of the complementary analyses of a real sample (long-eared owl) by GC-MS/MS (A) and by LC–MS/MS (B).
Figure 1. MRM chromatograms of the complementary analyses of a real sample (long-eared owl) by GC-MS/MS (A) and by LC–MS/MS (B).
Toxics 09 00238 g001
Figure 2. Occurrence of environmental pollutants in the liver of a series of 151 wild birds of the Canary Islands.
Figure 2. Occurrence of environmental pollutants in the liver of a series of 151 wild birds of the Canary Islands.
Toxics 09 00238 g002
Figure 3. Study of the determinants of environmental contamination detected in the livers of wild birds in the Canary Islands: Habitat type (terrestrial (TB) vs. aquatic birds (AQB)).
Figure 3. Study of the determinants of environmental contamination detected in the livers of wild birds in the Canary Islands: Habitat type (terrestrial (TB) vs. aquatic birds (AQB)).
Toxics 09 00238 g003
Figure 4. Study of the determinants of environmental contamination detected in the livers of wild birds in the Canary Islands: Diet type (raptors vs. non-raptors).
Figure 4. Study of the determinants of environmental contamination detected in the livers of wild birds in the Canary Islands: Diet type (raptors vs. non-raptors).
Toxics 09 00238 g004
Figure 5. Study of the determinants of environmental contamination detected in the livers of wild birds in the Canary Islands: Habit type (diurnal vs. nocturnal).
Figure 5. Study of the determinants of environmental contamination detected in the livers of wild birds in the Canary Islands: Habit type (diurnal vs. nocturnal).
Toxics 09 00238 g005
Table 1. Median concentrations and frequencies (between parentheses) of organic pollutants detected in wild birds of the Canary Islands. All the results are in ng/g.
Table 1. Median concentrations and frequencies (between parentheses) of organic pollutants detected in wild birds of the Canary Islands. All the results are in ng/g.
CompoundAccipiter Nisus (n = 5)Ardea Cinerea (n = 12)Asio Otus (n = 34)Burrinus Oecdinemus (n = 10)Buteo Buteo (n = 12)Calonectris Diomedea (n = 8)Ciconia Ciconia (n = 2)Corvus Corax (n = 16)Egretta Garzetta (n = 4)Falco Eleonorae (n = 2)Falco Pelegrinoides (n = 6)Falco Tinnunculus (n = 14)Larus Michaelis (n = 14)Turdus Merula (n = 4)Tyto Alba (n = 8)
Meloxicam9.9
(40)
-47.8
(12)
880.3 *
(20)
---10.3
(13)
---96.1
(29)
---
Tetraconazole--0.6
(6)
------------
Clindamycin1.3
(40)
-1423 *
(18)
1.4
(20)
28.4
(33)
-----2.3
(33)
----
Enrofloxacin5300 *
(80)
-4739 *
(29)
4638 *
(40)
5453 *
(67)
--1970 *
(13)
-20.4
(100)
5144 *
(50)
5531 *
(57)
10234 *
(7)
-14508 *
(50)
Metronidazole---50.8
(10)
-------603.3
(14)
---
Sulfatiazole--15.5
(6)
------------
2-Phenylphenol--16.3
(18)
22.7
(20)
2.4
(17)
----------
Boscalid (formerly nicobifen)--------------0.2
(25)
Fludioxonil--0.4
(6)
------------
Fluquinconazole---------------
Flutriafol----4.4
(17)
----------
Carbofuran--10.3
(3)
16.4
(10)
7.2
(26)
--94.5
(38)
-------
Carbofuran-3-hydroxy-------2.1
(38)
-------
Fipronil--1.4
(12)
------------
Fipronil sulfide--3.0
(6)
------------
Permethrin-----23.4
(13)
------12.3
(7)
--
Acenaphthene2.4
(80)
1.4
(17)
0.8
(18)
-0.4
(17)
------2.4
(14)
---
Anthracene1.5
(40)
--------------
Chrysene--------------4.8
(25)
Fluoranthene0.4
(40)
-------------1.7
(25)
Fluorene5.9
(80)
-2.5
(12)
--------5.3
(7)
---
Naphtalene1.8
(100)
-2.2
(6)
5.7
(40)
3.9
(26)
16.6
(13)
-3.4
(26)
0.7
(25)
--1.8
(14)
-0.9
(50)
8.0
(25)
Phenanthrene13.3
(100)
-7.5
(12)
--0.4
(13)
-2.7
(13)
---7.6
(28)
--851.3
(50)
Pyrene1.8
(40)
-0.7
(9)
--------20.0
(28)
---
4,4′-Dichlorobenzophenone (metabolite of dicofol)---------------
BDE-100-1.9
(33)
0.2
(6)
-------0.4
(33)
-0.2
(7)
--
BDE-153-0.3
(33)
4.9
(41)
--1.1
(13)
---0.7
(50)
19.0
(67)
0.6
(29)
--0.8
(25)
BDE-154-2.1
(17)
2.6
(6)
-------6.9
(33)
----
BDE-183--0.9
(12)
------------
BDE-47-1.5
(17)
2.4
(6)
--------0.6
(7)
0.4
(14)
--
BDE-99--1.5
(29)
-------3.6
(33)
0.4
(14)
0.6
(14)
7.5
(100)
0.4
(13)
Dichlorodiphenyldichloroethane (p,p′ DDD)1.2
(80)
----------2.2
(21)
---
Dichlorodiphenyldichloroethylene (p,p′ DDE)211.1
(100)
21.1
(100)
305.6
(100)
25.9
(60)
5.6
(83.3)
16.6
(100)
-6.7
(75)
4.7
(100)
68.4
(100)
318.6
(100)
45.3
(100)
4.4
(100)
-24.1
(100)
Dieldrin7.8
(80)
3.5
(17)
5.6
(41.2)
3.0
(10)
0.9
(33)
3.1
(13)
--2.1
(100)
5.8
(100)
8.5
(100)
11.9
(100)
2.3
(7)
-1.2
(75)
Hexachlorobencene-1.4
(34)
0.6
(24)
--7.1
(13)
--12.9
(50)
0.6
(50)
-1.1
(7)
1.1
(7)
-0.8
(25)
Hexachlorocyclohexane (beta)--31.0
(12)
-------3.4
(50)
---
Mirex--3.9
(12)
3.6
(20)
3.1
(17)
25.0
(13)
----2.3
(33)
---
PCB 105-1.2
(50)
1.3
(35)
--2.0
(26)
--3.6
(25)
0.6
(50)
0.6
(67)
1.1
(14)
0.4
(7)
--
PCB 1180.5
(40)
5.4
(50)
4.8
(35)
-0.5
(17)
45.1
(13)
--14.9
(50)
5.0
(100)
2.2
(100)
1.3
(28)
1.4
(7)
-1.2
(37)
PCB 1381.4
(80)
7.9
(100)
2.9
(76)
2.2
(30)
1.3
(34)
8.8
(75)
-3.9
(38)
24.1
(100)
15.3
(100)
7.7
(100)
4.2
(71)
2.7
(72)
-5.3
(75)
PCB 1533.4
(80)
15.5
(100)
3.6
(94)
0.5
(80)
3.3
(34)
6.8
(100)
-1.7
(88)
55.3
(100)
115.3
(100)
16.0
(100)
5.7
(71)
--7.8
(100)
PCB 156-2.0
(50)
2.0
(33)
--8.5
(13)
--0.8
(25)
8.8
(50)
0.8
(100)
0.9
(7)
--0.5
(25)
PCB 157-0.8
(17)
1.1
(6)
--2.1
(13)
--9.1
(50)
1.1
(50)
--0.4
(7)
--
PCB 167-1.7
(50)
1.5
(35)
--6.7
(50)
--44.6
(100)
6.7
(50)
1.3
(67)
0.8
(14)
2.2
(72)
-0.4
(13)
PCB 1803.9
(80)
24.3
(67)
3.2
(88)
-2.1
(50)
3.6
(100)
-2.8
(88)
-123.6
(100)
19.8
(100)
5.2
(71)
--8.0
(75)
PCB 189--2.1
(6)
1.0
(80)
-----1.8
(50)
-----
PCB 28--5.8
(3)
------------
Brodifacoum1.7
(100)
0.4
(100)
32.9
(100)
2.3
(80)
0.9
(100)
--27.4
(75)
--20.4
(100)
8.8
(50)
1.4
(21)
-20.31
(100)
Bromadiolone--1.3
(100)
2.1
(100)
8.5
(100)
--2.25
(38)
-1.1
(50)
4.6
(100)
2.5
(75)
-0.34
(25)
2.2
(75)
Difenacoum-0.8
(17)
0.6
(24)
-1.5
(50)
--0.9
(13)
--0.9
(33)
1.2
(57)
--3.6
(25)
Difethialone--18.9
(18)
--------1.9
(29)
---
Flocoumafen--0.7
(24)
-4.1
(17)
------2.2
(7)
---
* These values cannot be considered as biomonitoring, since these pharmaceuticals were employed during the treatment of the animals at the Wildlife Recovery Centers.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Rial-Berriel, C.; Acosta-Dacal, A.; Zumbado, M.; Henríquez-Hernández, L.A.; Rodríguez-Hernández, Á.; Macías-Montes, A.; Boada, L.D.; Travieso-Aja, M.d.M.; Martin Cruz, B.; Luzardo, O.P. A Method Scope Extension for the Simultaneous Analysis of POPs, Current-Use and Banned Pesticides, Rodenticides, and Pharmaceuticals in Liver. Application to Food Safety and Biomonitoring. Toxics 2021, 9, 238. https://doi.org/10.3390/toxics9100238

AMA Style

Rial-Berriel C, Acosta-Dacal A, Zumbado M, Henríquez-Hernández LA, Rodríguez-Hernández Á, Macías-Montes A, Boada LD, Travieso-Aja MdM, Martin Cruz B, Luzardo OP. A Method Scope Extension for the Simultaneous Analysis of POPs, Current-Use and Banned Pesticides, Rodenticides, and Pharmaceuticals in Liver. Application to Food Safety and Biomonitoring. Toxics. 2021; 9(10):238. https://doi.org/10.3390/toxics9100238

Chicago/Turabian Style

Rial-Berriel, Cristian, Andrea Acosta-Dacal, Manuel Zumbado, Luis Alberto Henríquez-Hernández, Ángel Rodríguez-Hernández, Ana Macías-Montes, Luis D. Boada, María del Mar Travieso-Aja, Beatriz Martin Cruz, and Octavio P. Luzardo. 2021. "A Method Scope Extension for the Simultaneous Analysis of POPs, Current-Use and Banned Pesticides, Rodenticides, and Pharmaceuticals in Liver. Application to Food Safety and Biomonitoring" Toxics 9, no. 10: 238. https://doi.org/10.3390/toxics9100238

APA Style

Rial-Berriel, C., Acosta-Dacal, A., Zumbado, M., Henríquez-Hernández, L. A., Rodríguez-Hernández, Á., Macías-Montes, A., Boada, L. D., Travieso-Aja, M. d. M., Martin Cruz, B., & Luzardo, O. P. (2021). A Method Scope Extension for the Simultaneous Analysis of POPs, Current-Use and Banned Pesticides, Rodenticides, and Pharmaceuticals in Liver. Application to Food Safety and Biomonitoring. Toxics, 9(10), 238. https://doi.org/10.3390/toxics9100238

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop